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MARTIN, KEITH R., Ph.D. Development of a Cellular Model to Evaluate the Hypothesis that 
Carotenoids are Antioxidants. (1996) Directed by Dr. Mark L. Failla. 120 pp. 
Numerous epidemiologic studies support an inverse association between consumption of 
carotenoid-rich fruits and vegetables and the incidence of some degenerative diseases in 
humans. One proposed mechanism centers on the role of carotenoids as antioxidants 
independent of their role as retinoid precursors. Antioxidants prevent the formation and quench 
the propagation of free radicals, the species that are generally considered as the etiologic basis 
for many diseases. The HepG2 liver and Caco-2 intestinal human cell lines were selected as 
potential models for investigating the role of carotenoids as antioxidants. Caco-2 cells 
spontaneously differentiate into polarized, enterocyte-like cells. HepG2 cells exhibit many of the 
activities of normal human liver parenchymal cells and secrete lipoproteins and numerous 
plasma proteins. Initially, the susceptibility of HepG2 and Caco-2 cells to several commonly used 
free radical generating pro-oxidants was examined. Both structural and functional parameters, 
e.g., plasma membrane permeability and amino acid and glucose transport, were adversely 
altered in HepG2 ceils exposed to the pro-oxidants. In contrast, Caco-2 cells were relatively 
resistant to the damaging effects of the pro-oxidants. These data supported the usefulness of the 
HepG2 human cell line as an appropriate model for investigation of potential cytoprotection 
conferred by carotenoids against free radical-mediated damage. 
Next, I examined the ability of HepG2 cells to accumulate p-carotene and lutein, 
carotenoids with and without pro-vitamin A activity, respectively, from micellar preparations after 
overnight incubation and the potential role of the carotenoids as cellular antioxidants. Cells were 
also incubated with a-tocopherol as a positve control, since the antioxidant properties of this 
compound are well established. HepG2 readily accumulated both carotenoids and a-tocopherol. 
Control and treated cells were exposed to a pro-oxidant stressor and the impact on several 
parameters of cellular function and plasma membrane integrity were evaluated. {3-Carotene and 
lutein, like a-tocopherol, markedly attenuated the adverse impact of pro-oxidant exposure on 
nutrient transport and cellular integrity. Protein synthesis, glucose oxidation and mitochondrial 
activity were not impaired by the pro-oxidant, suggesting that the plasma membrane was the site 
of damage. 
Research using cell culture systems has been problematic due to the considerable 
hydrophobicity of carotenoids in aqueous systems and the difficulty of presenting carotenoids in 
a bioavailable form. These compounds are usually introduced into tissue culture medium either 
in organic solvents or as micelles, whereas carotenoids are localized in lipoproteins in plasma. 
Thus, we speculated that carotenoid-enriched human lipoproteins would be an effective vehicle 
for delivery of p-carotene and a-tocopherol to HepG2 cells. Volunteers ingested either p-
carotene supplements (60 mg/day) or placebo for 4 weeks to enrich plasma lipoproteins with p-
carotene. The concentration of p-carotene in plasma of supplemented subjects was significantly 
increased (p < 0.05) by greater than 11-fold after 4 weeks. After isolating total lipoproteins, the 
stability of p-carotene and a-tocopherol in micelles and human lipoproteins was compared. 
Micellar p-carotene, but not lutein and a-tocopherol, was markedly oxidized under cell-free 
culture conditions. In contrast, p-carotene was relatively stable in cell-free medium containing 
total lipoproteins isolated from p-carotene supplemented individuals. Cellular accumulation of 
p-carotene and a-tocopherol was proportional to the concentrations of these lipophilic 
compounds in total lipoproteins, low density lipoproteins, or high density lipoproteins. These and 
other data show that lipoproteins represent a stable, physiologically relevant vehicle for delivery 
of p-carotene and a-tocopherol to HepG2 human liver cells. 
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CHAPTER I 
INTRODUCTION 
OVERVIEW 
Since their initial discovery in the mid-19th century, hundreds of carotenoids have been 
identified and characterized. All carotenoids are variants of the parent compound. 
Carotenoids are synthesized by all plants and photosynthetic microorganisms, but not by 
mammals (Pfander, 1992). Humans ingest several milligrams of carotenoids daily by eating fruits 
and vegetables (Lachance, 1988). Because approximately 10% of the known carotenoids, and 
particularly (3-carotene, possess provitamin A activity, consumption of carotenoid-enriched foods 
is of particular interest in developing countries as a means of alleviating vitamin A deficiency 
(Solomons and Bulux, 1993). 
One focus of recent inquiry concerns the potential antioxidant activity of carotenoids. 
These pigments are involved in light harvesting reactions and quench singlet oxygen-induced 
damage to sensitive plant organelles. Because free radical-mediated damage to mammalian 
tissues is believed to be the etiologic basis for the aging process and for degenerative diseases 
such as arthritis, cataracts, some forms of cancer and coronary heart disease (Canfield et al., 
1992; Thumham, 1994), it has been proposed that dietary carotenoids also may function as 
antioxidants in mammalian tissues. This possibility is supported by numerous epidemiologic 
studies that have demonstrated an inverse correlation between the intake of fruits and 
vegetables and the incidence of diseases such as cancer (van Poppel and Goldbohn, 1995). 
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Possible mechanisms by which carotenoids may protect tissues against oxidative damage 
include their inherent antioxidant activity, interactions with other antioxidants, conversion to 
retinoids or apocarotenoids, and modulation of enzyme activities that are part of the host 
antioxidant system (Canfield et al., 1992). Additionally, various studies have supported the roles 
for carotenoids as: a) blockers of neoplastic transformation (Bertram and Bortkiewicz, 1995), b) 
inducers of remission of oral leukoplakia (Garewal, 1995), c) quenchers of free radicals such as 
singlet oxygen (Sies and Stahl, 1995), and d) modulators of immune activity (Meydani et al., 
1995). 
In order for dietary carotenoids to protect cells and tissues against oxidative stress, foods 
containing these compounds must first be digested to release the carotenoids for their 
incorporation into lipid micelles in the small intestine. Intestinal mucosal cells then transfer the 
intact carotenoid or its metabolic products to lymphatic and/or portal circulation for delivery, 
utilization and storage in peripheral tisues (Erdman, 1988). Carotenoids are either absorbed 
intact or cleaved to retinoids or apocarotenals and packaged into chylomicrons for transport via 
lymph. Peripheral tissues such as adipose and the adrenal glands accumulate relatively high 
levels of these hydrophobic compounds. The liver also accumulates carotenoids via the uptake 
of chylomicron remnants. Specific characteristics and regulation of many of these processes of 
carotenoid transport and metabolism remain largely unknown, primarily because of the lack of 
appropriate animal models until recently. Although there is a plethora of literature using 
laboratory rodents, these animals do not absorb carotenoids as efficiently as humans (Erdman, 
1988). The ferret, preruminant calf and Mongolian gerbil are now recognized as excellent animal 
models for the study of carotenoid absorption and metabolism. Unfortunately, the availability 
and/or special maintenance requirements for these animals limits their use. 
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The development of alternative models for investigating carotenoid function and 
metabolism in humans is necessary. Human cell lines would appear to represent potential 
models. The availability of highly differentiated human cell lines with phenotypic properties 
similar to enterocytes and hepatocytes appear to be particularly relevant. The intestine is 
constantly exposed to ingested xenobiotics, transition metals and oxidants such as lipid 
hydroperoxides that are present in the typical diet and may cause free radical-mediated tissue 
damage. Similarly, the liver is an active site of xenobiotic metabolism that generates high levels 
of free radical compounds. Finally, both the intestine and the liver also have important roles in 
the transport and metabolism of dietary carotenoids. 
STRUCTURE OF CAROTENOIDS 
Over 700 distinct carotenoids have been identified and characterized as either 
hydrocarbon carotenes or oxygen-containing xanthophylls (Khachik, 1995). Approximately 10% 
of the carotenoids are carotenes and the remaining 90% are xanthophylls. The diversity of the 
carotenoids centers on the potential for numerous structural modifications and stereochemical 
variations of the parent compound lycopene. Lycopene, a red pigment found in tomato products, 
possesses eight isoprenoid units and a series of 13 conjugated double bonds. Cyclization, 
hydrogenation, dehydrogenation, bond migration and spatial rearrangement are responsible for 
the diverse family of carotenoids (Fig. 1.1). Olson (1995) has estimated that there may be more 
than 220,000 different carotenoids in nature. Common structural features within this family of 
compounds include a 40 carbon backbone with eight isoprenoid units forming an extensive 
conjugated diene system, molecular symmetry, and, typically, a cyclic p-ionone ring system at 
either end of the molecule. Derivatives in which the carbon skeleton has been shortened (<8 
isoprenoid units) or elongated (>8 isoprenoid units) are named apocarotenals and 
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p-Carotene 
Lutein 
OH 
Lycopene 
/3-Cryptoxanthin 
a-Carotene 
Fig. 1.1. Structures of five carotenoids found in human plasma 
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homocarotenals, respectively. Cleavage of the central 15,15' bond produces two molecules of 
retinal, or vitamin A, in compounds with unsubstituted rings. Cleavage of oxycarotenoids 
containing substituted ring systems does not generate vitamin A in mammals. 
AVAILABILITY. ABSORPTION AND TISSUE DISTRIBUTION OF CAROTENOIDS 
Carotenoids are synthesized by plants and photosynthetic microorganisms from acetyl-
coenzyme A by a series of well defined condensation reactions (Olson, 1989). Annual production 
of carotenoids is estimated at 100 million tons arising predominantly from algae in the oceans 
and plants on land (Daun, 1988). Carotenoids are present in vegetables, vegetable oils and 
animal products where they impart the readily observable yellow, orange and red colors. While 
plants typically contain a variety of carotenoids, specific carotenoids may predominate in a food 
item, e.g. p-carotene in carrots, lycopene in tomatoes, and lutein in kale. Green leafy vegetables 
contain 80-90% xanthophylls and 10-20% (3-carotene, whereas yellow and orange fruits and 
vegetables are poor in oxycarotenoids but rich in the hydrocarbon carotenes. In green plants, the 
pigment chlorophyll typically obscures the presence of the colorful carotenoids. Although 
carotenoids naturally occur in the food supply, only three carotenoids have been approved as 
food additives by the Food and Drug Administration, viz., 0-carotene, canthaxanthin and p-apo-
8'-carotenal. 
The types and amounts of carotenoids in foods are affected by many factors, including 
variety of crop, cultivation methods, and season and stage of maturity at harvest (Gerster, 1993). 
The potential for variation of carotenoid composition in foods has been one of many 
considerations in attempts to accurately estimate the intake of carotenoids by individuals in the 
U.S. Technological advances in instrumentation and development of improved analytical 
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procedures have resulted in the availability of more accurate and complete food composition 
tables (Chug et ai., 1993). 
Approximately 100 carotenoids are present in the typical U.S. diet (Chug et al., 1993). 
Current estimates indicate a daily consumption of carotenoids in the U.S. of 1.5*2.0 mg. The 
Food and Nutrition Board of the National Academy of Sciences has concluded that 
approximately one-third of ingested p-carotene is absorbed and about one-half of this is 
converted to retinoids, resulting in 15-20% efficiency of utilization. Although p-carotene is a 
source of vitamin A, there is no RDA for p-carotene or other carotenoids at this time. Review of 
suggested dietary practices by the National Cancer Institute and the United States Department of 
Agriculture, as well as epidemiological and food disappearance surveys, have defined a range of 
optimal intake that is associated with reductions of many disease processes. The disparity 
between actual consumption patterns and the suggested intake of 5.2-6.0 mg/day have revealed 
a "carotene gap." Unfortunately, only 9% of the U.S. population consumes the recommended 3-5 
servings of fruits and vegetables suggested in the food guide pyramid (Frei, 1994). Moreover, 
the most commonly consumed fruit or vegetable is the potato, a poor source of carotenoids 
(Lachance, 1988). 
While fruits and vegetables offer a plethora of potentially beneficial phytochemicals, p-
carotene supplementation has become common due to its increased availability and apparent 
lack of toxicity (Diplock, 1995). This practice has also been promoted by recent data indicating 
that consumption of increased amounts of plants by vitamin A deficient individuals is less 
effective at improving retinoid status than oral supplementation with p-carotene (de Pee et al., 
1995). Supplementation of <180 mg/day daily for years does not appear to produce detrimental 
side effects in humans, although nontoxic yellowing of the skin may occur at intakes >30 
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mg/day. Treatment of patients with erythropoietic protoporphyria (EPP) who have ingested up to 
300 mg p-carotene/day for long periods of time has resulted in few side effects, e.g. 
carotenodenmia and mild occassional gastrointestinal distress. Other carotenoids have not been 
investigated in detail. However, it is assumed that they will be as safe as p-carotene because of 
their structural similarities (Krinsky, 1988). 
Humans appear to absorb both carotenes and xanthophylls in a relatively non-specific 
fashion. Ingested carotenoids are emulsified into amphipathic micelles in the lumen of the small 
intestine by their interaction with pancreatic and biliary secretions (Erdmanr 1988). 
Approximately 10-50% of ingested carotenoid may be taken up by mucosal cells. However, a 
number of factors can influence absorption and utilization of carotenoids. These include the 
amounts of dietary carotenoids and fat, the types of dietary fatty acids, digestability of food, 
presence of other food components including antioxidants and fiber, vitamin A, protein and zinc 
status, disease states, use of therapeutic drugs, hormone status and weight changes (Erdman, 
1988). After uptake by the enterocyte, carotenoids may be cleaved centrally or excentrically by 
the putative 15,15'-dioxygenase (EC 1.13.11.21) to form chain shortened apocarotenals or polar 
retinoids, or remain intact and combine with phospholipids, triglycerides, cholesterol and its 
esters to form chylomicrons. After movement across the basolateral surface of the enterocyte, 
chylomicrons are transported via the lymphatic system to the peripheral circulation. The 
endothelium-anchored enzyme lipoprotein lipase cleaves triglycerides and the released fatty 
acids and possibly carotenoids are transferred from the lipid particle to the peripheral tissues. 
The resultant chylomicron remnant is taken up by the liver by receptor-mediated endocytosis. In 
this tissue, the newty acquired carotenoid may be cleaved to retinoids or other metabolites, 
stored intact, or incorporated into other lipoproteins, viz., very low density (VLDL), low density 
(LDL) or high density lipoproteins (HDL), for distribution to extrahepatic tissues. 
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Plasma carotenoids are distributed among the various classes of lipoproteins based on 
relative polarity of the individual carotenoid. Hydrophobic carotenes (e.g. p-carotene) are located 
primarily in LDL (-70%) with lesser amounts in HDL (-20%) and VLDL (-10%). In contrast, polar 
xanthophylls are distributed more evenly among lipoprotein classes with -45% present in LDL 
and HDL with the balance in VLDL. Carotenoids concentrate in those tissues expressing large 
numbers of LDL receptors (Gerster, 1993). Recent studies have shown that carotenoids, viz., p-
carotene, may be transferred or exchanged between groups of lipoproteins in circulation (Wang, 
1994). 
Human plasma contains about 1% of the total body pool of carotenoids (100-150 mg) 
and contains a complex mixture of structurally diverse carotenoids that generally reflect dietary 
intake over recent weeks or months (Packer, 1989). Approximately 21 carotenoids have been 
identified in human plasma with six comprising >90% of the total amount present. These include 
p-carotene (-22%), lutein (-20%), lycopene (22-35%), p-cryptoxanthin (-10%) and smaller 
amounts of zeaxanthin and a-carotene. Typical plasma levels are 200-400 ng/dL and are highly 
dependent on diet. Factors such as destruction in the gastrointestinal tract, efficiency of 
absorption and metabolism, and rate of tissue uptake may affect plasma levels of carotenoids 
(Gerster, 1993). 
Humans can absorb small, but significant, amounts of non-modified carotenoids and 
accumulate very high concentrations of the carotenoids in peripheral tissues without toxic effects 
(Wang et al., 1992). Levels and profiles of carotenoids in tissues likely reflect the pattern of 
consumption of fruits and vegetables over many years (Packer, 1989). The whole body content 
of carotenoids has been estimated at 140 mg with about 84% present in adipose tissue and 10% 
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in liver. In fact, some 30 different carotenoids have been identified in adipose tissue in humans 
and the levels can vary by as much as a 40-fold between individuals. Although the accumulation 
of carotenoids in tissues is generally nonspecific, several examples of tissue selectivity are 
known. The macular pigment and the retina primarily contain zeaxanthin and lutein, respectively 
(Thumham, 1994). In contrast, lycopene represents 60-80% of the carotenoids present in the 
testes and adrenal glands (Gerster, 1993). The biochemical basis for the observed specificity of 
carotenoid accumulation by some tissues is unknown. 
The metabolic fate of ingested carotenoids in human organisms remains virtually 
unknown, except for the conversion of provitamin A carotenoids to vitamin A metabolites (i.e., 
retinol and retinyl ester). Xanthophylls such as lutein have no detectable provitamin A activity 
(Gerster, 1993). Biotransformation of p-carotene to apocarotenals and retinoids has been 
recently demonstrated in human intestinal homogenates (Wang, 1991). Animals such as fish 
may convert carotenoids that are generally assumed to lack provitamin A actvity in humans to 
retinoids. 
PROPOSED FUNCTIONS OF CAROTENOIDS 
a. Provitamin A activity of carotenoids 
The classic pathologic consequence of vitamin A deficiency, viz., blindness, has been 
recognized for millenia. Evidence collected over the past 20 years has shown that subclinical 
deficiency of vitamin A adversely affects normal growth, resistance to infection, and 
maintenance of ocular integrity, particularly in children in developing countries (Sommer, 1989). 
Provitamin A carotenoids such as p-carotene are oxidatively cleaved to form vitamin A and 
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shorter apocarotenals (12', 10', 81) by the partially characterized enzyme 15,15'-dioxygenase in 
intestinal cells and the liver (Gerster, 1993). There is no other apparent metabolic route to 
vitamin A in animals. 
In vivo studies have shown that conversion of p-carotene to vitamin A via excentric 
cleavage is only 40-60% as efficient as central cleavage. Wang (1994) has reported cleavage of 
|3-carotene and [3-apocarotenals to vitamin A in intestinal homogenates from several species 
including humans. Additionally, the dioxygenase activity appeared to be inversely related to the 
levels of carotenoids in the diet in several animal studies. Animal studies have also shown that p-
carotene is capable of rapidly compensating localized vitamin A deficiency induced by 
carcinogens by promoting the expression of genes controlling cell differentiation (Van Poppel, 
1993). 
b. Immunomodulatory activity of carotenoids 
Characteristics of the immune system include adaptation, specificity, and long-term 
memory to protect the host against viruses, pathogenic microorganisms and cancer cells. The 
immune response often centers on the cell-mediated and humoral branches that are composed 
of two populations of morphologically indistinguishable lymphoid cells, viz., the B and T 
lymphocytes, respectively. In addition to lymphocytes, the immune system contains accessory 
cells such as plasma cells, monocytes, basophils, polymorphonuclear leukocytes, dendritic 
reticular cells, and large granular lymphocytes (natural killer cells). 
The cellular redox status can affect the integrity and function of membrane lipids, 
cellular proteins, and nucleic acids, signal transduction processes and gene expression in 
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immune cells (Meydani et al., 1995). The role of carotenoids in the enhancement of the immune 
system has been investigated using several models. For example, supplementation studies with 
humans have revealed that retinol and p-carotene increase the number and activities of natural 
killer cells and the percentages of cells expressing surface activation markers such as transferrin 
and interleukin-2 receptors. Supplementation with |3-carotene has also been shown to increase 
the percentage of T helper cells (CD4+) without adversely affecting the population of T cytotoxic 
cells (CD8+). 
In several animal studies, the carotenoids p-carotene and canthaxanthin have been 
shown to enhance mitogenic reactivity of T and B lymphocytes. p-Carotene supplementation of 
hamsters with chemically-induced tumors markedly increased the numbers of cytotoxic T cells. 
Krinsky et al. (1991) reported that supplementation with p-carotene slowed the growth and 
induced the regression of virus-induced tumors implanted in mice. Supplementation with p-
carotene also increased immunoresponsiveness upon subsequent rechallenge with tumors, p-
Carotene has been shown to protect murine thymus, lymphocytes and macrophages against 
stress-, radiation- and oxidant-induced damage, respectively (Thumham, 1994). Numerous in 
vitro and in vivo studies have shown that p-carotene protects phagocytic cells from autooxidative 
damage, stimulates effector T cell function, enhances the bactericidal capacity of macrophages, 
cytotoxic T cells and natural killer cells, and increases the production of interleukins such as 
tumor necrosis factor. The ability of p-carotene and carotenoids without provitamin A activity to 
modulate immune responses provides evidence that this activity is not necessarily dependent on 
the production of retinoids (Bendich, 1988). 
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c. Antioxidant activity of carotenoids 
Numerous studies have utilized both pro- and nonprovitamin A carotenoids to investigate 
the antioxidant function of carotenoids and the relative importance and dependence on 
provitamin A activity for this action. The uniqueness of the carotenoids has centered on their 
diversified roles in light energy absorption, oxygen transport, protection against photosensitized 
oxidation, provitamin A activity, use as food colorants, quenchers of singlet oxygen, regulators of 
plant growth, and more recently as inhibitors of chemical carcinogenesis (Daun, 1988). 
Recognition that the antioxidant capacity of p-carotene was linked to the length of the polyene 
chain led to the demonstration that non-p-carotene compounds possessing at least 7-9 
conjugated double bonds were useful as quenchers of singlet oxygen and free radical traps. The 
literature contains numerous studies that have considered the putative antioxidant activity of the 
carotenoids. Selected examples from human, animal and cellular studies are discussed below. 
Human studies. Overall, evidence from retrospective studies in which estimated food intake of 
patients with cancer prior to or at the time of diagnosis was compared with estimates of intake of 
matched subjects strongly suggests that consumption of dark leafy or dark yellow-orange 
vegetables decrease the risk of some cancers, e.g., lung cancer (van Poppel and Goldbohn, 
1995). Review of prospective dietary studies have supported the contention that the increased 
risk of some cancers, and particularly of the lung, decreases markedly with increased intake of 
fruits and vegetables. Most epidemiologic studies concerned the requirement for conversion of 
carotenoids to retinoids for anticarcinogenic action. Despite its important role in normal cell 
differentiation, increased intake of preformed vitamin A has not been associated with significant 
decreases in the risk of some cancers. 
13 
Individuals who smoke or chew tobacco products exhibit increased formation of 
micronucleated cells, which is indicative of chromosomal damage due to the nitrosoamines and 
other carcinogens in tobacco (Garewal, 1995). The presence of micronuclei and nuclei with 
changed textures precedes development of oral leukoplakia. p-Carotene (180 mg/week) and 
vitamin A supplementation significantly reduced the frequency of micronuclei in the oral mucosa 
of betel quid chewers and snuff dippers. p-Carotene supplementation also induced regression of 
new leukoplakia, even in subjects who continued to use tobacco products. Dysplasia of the 
uterine cervix is another marker of preneoplastic lesions (Meyskens and Manetta, 1995). In a 
group of females attending a family planning clinic, those with cervical dysplasia had significantly 
lower plasma levels of p-carotene than those exhibiting normal cytology of the cervix. The 
disease-free interval was prolonged after supplementation with 24 mg p-carotene and 36 mg 
canthaxanthin daily, for several months in patients after surgery for cancer of the breast, lung, 
urinary bladder or head and neck. In another study, individuals consuming a variety of fruits and 
vegetables [viz., p-carotene-rich carrots, mangos, papaya, lycopene-rich tomatoes, and lutein-
rich dark green leafy vegetables] exhibited inverse relationships between intake of p-carotene 
and the occurrence of lung cancer (van Poppel and Goldbohm, 1995). There also was a strong 
impact of consumption of lycopene and lutein enriched vegetables against the incidence of 
cancer. The greatest protective effect was observed for individuals consuming combinations of 
all vegetables indicated above. Several other studies have shown that increased intake of fruits 
and vegetables is associated with elevated blood levels of carotenoids and the decreased 
occurrence of some cancers (Gerster, 1993). 
The role of carotenoids in protecting delicate plant organelles against potentially 
damaging photosensitized molecules is widely accepted. Matthews-Roth (1982) proposed that 
since carotenoid pigments could protect algae and bacteria from the harmful effects of light, 
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these pigments might also protect human tissues from similar oxidative stress. This led to the 
widespread and therapeutic use of high doses of p-carotene combined with canthaxanthin for 
patients with the genetic photosensitivity disease erthyropoietic protoporphyria. The successful 
outcome of therapeutic use of carotenoids has prompted further studies in animals. 
Age related macular degeneration (AMD) is a degeneration of the retina and the retinal 
pigment epithelium in the macula region of the mammalian eye. It is the leading cause of 
blindness in the U.S. and no treatment is currently available (Snodderly, 1995). An extensive 
body of literature from experiments with primates, rodents and other vertebrates shows that the 
retina is damaged by visible light. One mechanism that has been proposed is the peroxidation of 
polyunsaturated membrane lipids in the retina. Epidemiologic data indicate that individuals with 
low plasma concentrations of carotenoids and antioxidant vitamins are at increased risk for AMD. 
Lutein and zeaxanthin are selectively accumulated by the retina and increasing evidence 
suggests that these carotenoids may help retard some of the destructive processes associated 
with AMD (Snodderly, 1995). 
The requirement of the mammalian eye for oxygen and light and the potential for 
uncontrolled production of reactive oxygen species appears to be related to the development of 
cataracts. In fact, depletion of antioxidants including the carotenoids compromises the function 
of the lens (Taylor et al., 1995). In human studies, individuals with high plasma levels of total 
carotenoids had <20% the prevalence of cataracts compared with persons with relatively lower 
total plasma carotenoid levels. Additional studies report decreased incidences of cataracts and 
associated problems in individuals with relatively higher plasma levels of carotenoids. 
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Numerous epidemiologic studies have supported the protective role of carotenoids in 
delaying and preventing the development of cardiovascular disease (Manson et al., 1993). 
Epidemiologic research has included ecologic examination, case-control studies, cross sectional 
and cohort studies for elucidating the inverse relationship between increased dietary 
consumption and plasma levels of carotenoids and mortality due to cardio- and cerebro-vascular 
disease (Kohlmeier and Hastings, 1995). Participants who had previously had a cardiovascular 
event (stable angina or coronary revascularization) and were supplemented with p-carotene (50 
mg every other day) experienced almost 50% fewer subsequent problems than those receiving 
placebo only (Thurham, 1994). initiation of cardiovascular disease is highly correlated with the 
oxidation, uptake and accumulation of plasma lipoproteins by immune cells. Oxidized LDL is 
avidly scavenged by macrophages and subsequently converted to foam cells in the arterial 
intima where they form fatty streaks and later atherosclerotic plaques. In vitro susceptibility of 
LDL to oxidation has been shown to correlate with clinical severity in persons recently having a 
heart attack. Two studies (viz., Jialal and Grundy, 1991; Lavy et al., 1992) reported increased 
resistance of LDL to oxidation in the presence of p-carotene. Similarly, lutein markedly extended 
the lag phase of Cu-stimulated LDL oxidation. Studies with adult smokers and cystic fibrosis 
patients have provided conflicting evidence that (3-carotene supplementation increased LDL 
resistance to oxidative stress (Thumham, 1994). LDL from smokers supplementing with p-
carotene was not protected against oxidative stress. In contrast, the oxidation of LDL in cystic 
fibrosis patients supplementing with p-carotene was significantly reduced when compared to 
control subjects. Five prospective case-controlled studies reported that decreased plasma p-
carotene levels were associated with increased risk of lung cancer. The majority of epidemiologic 
evidence supports the protective effect of p-carotene, carotenoids as a group, and carotenoid-
rich foods against the development of cardiovascular disease (Kohlmeier and Hastings, 1995). 
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Animal studies. Extrapolation of animal findings to humans is limited because the uptake and 
metabolism of carotenoids is species-specific and the development of cancer in animals does 
not closely mimic carcinogenesis in humans (Gerster, 1993). In numerous studies utilizing 
rodents as models, viz., hamsters, mice and rats, supplementation with (3-carotene and/or 
canthaxanthin significantly reduced chemical- and radiation-induced tumorigenesis and 
carcinogenesis (Krinsky, 1991). The marked protection against carcinogenesis after 
supplementation with p-carotene and canthaxanthin, carotenoids with and without provitamin A 
activity, respectively, suggest a mechanism independent of conversion to retinoids. 
Carcinogenesis of epithelial origin, which accounts for >95% of cancers in man, were induced in 
several animal models at sites other than skin or mucosa including salivary glands, respiratory 
tract, colon, stomach and breast (Gerster, 1993). In studies using site-specific carcinogens, 
supplementation with carotenoids significantly reduced initiation and progression of chemically-
induced tumors. Collectively, numerous animal studies have provided compelling evidence for 
the role of carotenoids as anticarcinogenic compounds. 
In vitro studies. The discovery that carotenoids quench potentially damaging singlet oxygen was 
an important advance in the understanding of the effectiveness of carotenoid pigments in 
preventing damage in photobiological systems. Many in vitro studies using cell-free models 
including artificial membranes have been aimed at demonstrating the antioxidant function of 
carotenoids against free radical-mediated damage initiated by light, chemicals and radiation 
(Krinsky, 1989). Furthermore, investigators have studied the autoxidation and coupled oxidations 
of carotenoids, radical-induced oxidations, the effects of various enzymes such as lipoxidases 
and peroxidases on carotenoids, and the kinetics of radical-carotenoid interactions. Collectively, 
results from numerous in vitro studies support the function of carotenoids as quenchers of 
chemically-induced free radicals in cell-free systems. 
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Cellular studies. Cell culture and other in vitro models offer useful tools to study the molecular 
mechanisms involving carcinogenesis and to identify factors as potential anticancer agents even 
though they may represent an oversimplification of the in vivo environment (Gerster, 1993). 
Initial findings supporting the role of carotenoids as antioxidants focused on inhibition of 
carotenogenesis in pigmented yeast and subsequent exposure to oxidative stress. Inclusion of p-
carotene in medium abolished the impact of oxidant-induced cytotoxicity on yeast growth 
(Krinsky, 1989). In several bacterial systems, incubation with carotenoids with and without 
provitamin A activity inhibited carcinogen- and radiation-induced mutagenesis. Extension of 
studies to mammalian cell culture have shown that carotenoids, viz., carotenes and xanthophylls, 
inhibit adverse pro-oxidant-induced biochemical and functional changes in cell models including 
polymorphonuclear leukocytes, fibroblasts obtained from mouse embryo and chicken, and 
Chinese hamster ovary cells (Krinsky, 1991; Lawior & O'Brien, 1995). Results from studies with 
several human cell models have supported the putative antioxidant activity of carotenoids 
against singlet oxygen-induced oxidative stress and chemically-induced neoplastic 
transformation (Bertram and Bortkiewicz, 1995). In vitro human models have been limited to 
cells of neural, lymphoid and keratinocyte origin. 
The similarity between retinoids and carotenoids in stabilizing carcinogen-initiated cells 
against subsequent transformation has lead to an interesting proposal (Betram and Bortkiewicz, 
1995). Gap junctions of cell membranes serve as channels for cell to cell communication and 
growth regulation. Thus, upregulation of junctional communication increases formation of 
channels and enhances intercellular communication. The decreased proliferation of carcinogen-
initiated cells inhibits progression to a neoplastic phenotype. (3-Carotene and canthaxanthin were 
as equipotent as retinoids at elevating junctional communication, thereby inhibiting progression 
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of initiated cells. Upregulation of gap junctional communication parallels increased formation of 
connexin 43, a gene coding for structural units of the gap junction. Carotenoids have been shown 
to inhibit plasma membrane oxidation and induce upregulation of connexin 43 expression. 
Human cell lines as models for evaluating carotenoid antioxidant activity 
Caco-2 is derived from a human colonic adenocarcinoma and has proved useful in many 
nutrient and drug transport studies. Caco-2 spontaneously differentiates at confluency into highly 
polarized enterocyte-like cells possessing well developed brush borders with microvilli and tight 
junctions (Pinto et a!., 1983). Caco-2 monolayers develop many of the morphological and 
functional characteristics of polarized absorptive epithelial cells, including synthesis of brush 
border hydrolases and basolateral secretion of lipoproteins (Hidalgo et al., 1989). HepG2 is 
derived from a human hepatocellular carcinoma and exhibits many of the activities of normal 
liver, including an inducible cytochrome P450 system and the secretion of lipoproteins and at 
least 17 major plasma proteins (Knowies et al., 1980; Javitt, 1993). It has been widely used for 
cytotoxicity studies involving xenobiotics. These two cell lines seem to represent suitable models 
for investigating problems related to the transport, metabolism and function of carotenoids in 
human intestine and liver. 
Several reports on carotenoid accumulation and cytoprotection by human cells were 
available when this project was intiated. However, these studies focused primarily on immune-
and fibroblast-derived cell lines further supporting the potential novelty of HepG2 and Caco-2 cell 
lines as models for assessing carotenoid metabolism and function. With this background, I 
defined the following Specific Aims. 
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Specific aims 
1. To compare the relative susceptibilites of the Caco-2 and HepG2 human cell lines to various 
oxidants to evaluate their appropriateness as models for testing the cytoprotective potential of 
selected carotenoids against oxidative stress. 
2. To assess the antioxidant potential of p-carotene and lutein in HepG2 cells. 
3. To examine the effectiveness of organic solvents, micelles and lipoproteins as vehicles for the 
delivery of carotenoids to HepG2 cells. 
The results from detailed studies addressing each specific aim are outlined in subsequent 
chapters. 
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CHAPTER II 
SUSCEPTIBILITY OF CACO-2 AND HEPG2 HUMAN CELL LINES TO OXIDATIVE STRESS 
ABSTRACT 
Free radical-mediated cellular damage has been proposed to be critically linked to 
degenerative processes associated with various diseases. The objective of this study was to 
compare the impact of several pro-oxidants on two highly differentiated human cell lines, viz., 
HepG2 and Caco-2. Anchored, differentiated cultures were treated with various concentrations of 
either tert-butylhydroperoxide (TBHP), hydrogen peroxide (HPX), menadione (MD), or2,2-
azobis(2-amidinopropane) hydrochloride (AAPH) for 90 minutes at 37°C. Pro-oxidant induced 
cellular damage was assessed by monitoring the following: 1) production of thiobarbituric acid 
reactive substances (TBARS); 2) release of lactate dehydrogenase (LDH) and 51 chromium 
(^Cr) from cells; 3) 14C-glucose oxidation; 4) transport of glucose and amino acid analogues; 
and, 5) mitochondrial activity. Exposure of HepG2 cultures to TBHP, HPX and AAPH generated 
higher concentrations of TBARS than in Caco-2 cultures treated with equimolar concentrations of 
the pro-oxidants. In contrast, MD treatment elevated TBARS to a greater extent in Caco-2 
cultures than in HepG2. Cellular loss of LDH and 51 Cr increased significantly in HepG2 cultures, 
but not in Caco-2 cultures in response to 500 nmol/L TBHP, HPX and MD. Likewise, treatment 
with pro-oxidants generally impaired U-14C-glucose oxidation and the uptake of 3H-2-
deoxyglucose (3H-DOG) and 3H-a-aminoisobutyric acid (3H-AIB) to a greater degree in HepG2 
cultures. The observed changes in the uptake of the glucose and alanine analogues after 
exposure to the pro-oxidants was not associated with a decline in mitochondrial activity. These 
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data demonstrate that HepG2 cultures exhibited greater susceptibility to oxidant-induced 
damage than cultures of Caco-2 in which pro-oxidants were added to the apical compartment. 
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INTRODUCTION 
Free radicals have been implicated as etiologic factors for a variety of degenerative 
conditions, including emphysema, cataracts, arthritis and inflammatory diseases. Both enzymatic 
and non-enzymatic antioxidants normally inactivate free radicals, thereby preventing their 
deleterious effects on the structure and function of cellular components. However, excessive 
generation of reactive metabolites can damage DNA, proteins and polyunsaturated fatty acids in 
cell membranes (Jaeschke, 1995). 
Isolated tissues, cells, organelles and lipoproteins have been used as models to 
characterize the adverse consequences and mechanisms of free radical-mediated processes. To 
better evaluate the potential significance of in vitro observations, it is important to study those 
tissues and cells that are likely targets of specific free radicals in situ. Hepatocytes are especially 
appropriate for investigation because they have a central role in the oxidative metabolism of 
nutrients, metabolites and xenobiotics. Although primary cultures of animal hepatocytes have 
been widely used to investigate the production, metabolism and cytotoxicity of free radicals, 
studies with human hepatocytes are limited (Moshage and Yap, 1992). Likewise, the intestine is 
exposed to relatively high levels of ingested pro-oxidants, but primary cultures of differentiated 
enterocytes are difficult to isolate and maintain in culture (Evans et al„ 1994). Highly 
differentiated human cell lines such as HepG2 and Caco-2 are widely used models for in vitro 
studies. The HepG2 cell line is derived from a human hepatocellular carcinoma, secretes plasma 
proteins and lipoproteins, possesses an inducible cytochrome P4S0 system, and retains many 
other differentiated functions that are often lost by primary cultures of hepatocytes (Knowles et 
al. 1980; Javitt, 1990). The Caco-2 cell line is derived from a human colonic adenocarcinoma 
and differentiates at confluency into a polarized cell that expresses brush border hydrolases and 
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vectorially secretes lipoproteins (Pinto et al., 1983; Hidalgo et ai., 1989). These properties have 
resulted in its widespread use for study of the uptake, metabolism and absorption of nutrients 
and drugs (Han et al., 1994). 
In the present study, we have compared the consequences of exposing cultures of 
HepG2 and Caco-2 cells to several commonly used pro-oxidants on cellular integrity and 
activities. Two of the pro-oxidants selected for investigation, viz., tert-butylhydroperoxide (TBHP) 
and hydrogen peroxide (HPX), have been reported to generate free radicals in part via iron 
catalyzed processes, whereas the pro-oxidants 2,2'-azobis(2-amidino)propane hydrochloride 
(AAPH) and menadione (MD) generate free radicals after thermoiytic cleavage and metabolic 
activation with redox recycling, respectively (Nalini and Balasubramanian, 1993; Farber et al., 
1990). The results indicate that HepG2 cells are generally more susceptible to oxidant-induced 
stress than Caco-2 cells. 
MATERIALS AND METHODS 
Supplies. All reagents were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise 
noted. AAPH was obtained from Polysciences Inc. (Warrington, PA). Uniformly labeled (U)-14C-
giucose (sp. act. 89 MBq/mmol), 14C-mannitol (sp. act. 1 TBq/mmol), sodium 51chromate (sp. 
act. 23.8 GBq/mg) and a-[methyl-3H]-aminoisobutyric acid (sp. act. 252 GBq/mmol) were 
purchased from DuPont/New England Nuclear (Wilmington, DE). 2-Deoxy-D-[2,6-3H] glucose 
(sp. act. 999 GBq/mmol) was obtained from Amersham (Arlington Heights, IL). Tissue culture 
flasks (75 and 25 cm^) and microporous membrane inserts (Falcon inserts with area of 4.9 cm  ̂
and 3 ^meter pore) were obtained from Bectin, Dickinson & Company (Lincon Park, NJ) and 
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multiple well dishes (15 and 35 mm diameter) were obtained from Costar Corp. (Cambridge, 
MA). 
Cell Culture. HepG2 and Caco-2 were purchased from American Type Culture Collection 
(ATCC, Rockville, MD) and stock cultures were maintained in T75 flasks. All experiments were 
performed using cells originating from a single ampule supplied by ATCC since some phenotypic 
characteristics of Caco-2 vary between batches (Herrold et al., 1993). For experiments, cells 
were seeded in multiwell plastic dishes (15 and 35 mm diameter) and incubated in a humidified 
atmosphere of air/C02 (95:5 v/v) at 37°C. HepG2 cultures (passages 80-90) were grown in MEM 
supplemented with 10% heat-inactivated fetal bovine serum, 1 mmol/L pyruvate, 2 mmol/L 
glutamine, 50 mg/L gentamicin, 0.5 mg/L fungizone and 15 mmol/L N-2-hydroxyethylpiperazine-
N-2-ethanesulfonic acid (HEPES), pH 7.0. Medium was replaced every 2 days for HepG2 
cultures and experiments were initiated at 1-3 days post-confluency. Caco-2 cells (passages 25-
35) were grown in DMEM supplemented with 7.5% fetal bovine serum and 7.5% Fetal Clone II 
(Hyclone Labs, Inc., Logan, UT), 15 mmol/L HEPES, 1% (v/v) nonessential amino acids, 2 
mmol/L glutamine, 50 mg/L gentamicin, and 0.5 mg/L fungizone, pH 7.0. Medium was replaced 
every 2 days until the monolayer was confluent. The levels of fetal bovine serum and Fetal 
Clone II in complete medium then were decreased to 5% each. Fresh medium continued to be 
provided every second day and experiments were performed at 10-12 days post-confluency 
when cells were highly differentiated (Hidalgo et al., 1989; Ellwood et al., 1993). 
Experiments were initiated after removal of spent medium and washing cultures grown 
on multiwell dishes or in flasks 3 times with prewarmed Hank's Balanced Salt Solution (HBSS) 
without phenol red at 37°C. Basal medium either alone (control) or containing indicated 
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concentrations of either TBHP, HPX, MD or AAPH was added and cultures were incubated at 
37°C for 90 minutes. 
Assessment of Oxidative Damage to Cells 
a. Lipid peroxidation. To measure thiobarbituric acid reactive substances (TBARS), a 
modification of the method by Buege and Aust (1978) was used. Briefly, 100 ^L 0.45 nmol/L 
butylated hydroxytoluene (BHT) in absolute ethanol was added to each well after exposure to 
pro-oxidant to quench further oxidative changes. After transferring one-half of the test medium to 
a 5 mL glass screw cap tube and discarding remaining medium, the monolayer was washed 
three times with HBSS. Cellular material was collected in 1 mL harvest solution (3.5 mmol/L 
sodium dodecylsulfate (SDS) containing 1 mmol/L disodium ethylenediaminetetraacetic acid) 
and sonicated once for 3-5 seconds using a Sonic 50 Dismembranator at 60% power output 
(Fisher Scientific, Pittsburgh, PA). One half of the sonicate (500 |*L) and 2 mL TBA solution (26 
mmol/L thiobarbituric acid, 920 mmol/L trichloroacetic acid (TCA), 7 mmol/L SDS in 250 mmol/L 
HCI) were added to the tube containing the sample of medium. Tubes were heated at 95°C for 
30 minutes and cooled in ice. After mixing, aliquots were centrifuged at 16,000 x g for 10 
minutes before the supemate was analyzed spectrophotometrically at 532 nm. 
Tetramethoxypropane was used as a standard and processed identically to test samples. Results 
are presented as pmol TBARS/mg cellular protein. 
b. Lactate dehydrogenase (LDH) release. Aliquots of medium were centrifuged for 5 minutes at 
1,000 x g at 25°C to remove any cells that may have detached. Monolayers were washed with 
HBSS and collected in 1 mL 1% (v/v) Triton X-100 to determine cellular LDH (EC 1.1.1.27) 
activity. Cellular material was sonicated once for 3-5 seconds and the samples were centrifuged 
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at 16,000 x g for 5 minutes. The reaction mixture contained 2.8 mL 0.1 mol/L phosphate buffer 
(pH 7.5) with 85 î mol/L nicotinamide adenine dinucleotide, 100 nL 23 mmol/L sodium pyruvate, 
and 500 ^L supemate from either undiluted medium or cell sonicate that was diluted 1:50 with 
phosphate buffer (Glascott et al., 1992). Pilot studies showed that the activity of purified LDH in 
medium was not altered by exposure to either 500 nmol/L TBHP, HPX or MD, or 25 mmol/L 
AAPH for 90 min at 37°C. The rate of change in absorption at 340 nm was monitored for 5 min 
(Beckman DU-64 UV/visible spectrophotometer, Fullerton, CA). The percentage of cellular LDH 
released to the medium was calculated as follows: 
%LDH release = [LDH activity in media / (LDH activity in media + LDH activity in cells)] x (100%) 
c.51 Chromium fCrt release. After incubating cultures overnight (20 hr) with medium containing 
37 kBq 51 Cr, monolayers were washed with HBSS and incubated with medium with or without 
test pro-oxidants for 90 min at 37°C. Aliquots of medium were collected and centrifuged at 700 x 
g for 5 min. Supematent was sampled and ®^Cr determined by gamma ray spectrometry 
(Packard Cobra II auto-gamma counter, Meridan, CT). Monolayers were washed, collected and 
sonicated as described above (LDH release). The amount of 51Cr in aliquots was measured to 
determine cellular51 Cr. The percent of cellular51 Cr released to the medium was calculated as 
follows: 
% 51 Cr release = [51Cr in medium / (51Cr in medium + 51 Cr in cells] x (100%) 
d. Paracellular transport of 1^C-mannitol. To determine if exposure of the apical surface of 
Caco-2 cells to pro-oxidants adversely affected the integrity of tight junctions, cultures were 
grown and maintained on microporous inserts as described by Han et al. (1994). Pro-oxidants 
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were added to DMEM in the apical compartment and cultures were incubated for 90 min at 
37°C. After washing with HBSS at 37°C, monolayers were exposed to complete medium 
containing 14C-mannitol (9.25 Bq/well) in the apical compartment, while the basolateral 
compartment received complete medium without label. Mannitol is transported across the 
monolayer via the paracellular route (Ranaldi et al., 1992). Determination of the rate of 14C-
mannitol flux across the monolayer has been described by Han et al. (1994). 
e. f14Cl-Glucose oxidation. Following exposure to the test oxidants for 90 min and washing, 
monolayers (T25 flasks) were incubated with 2 mL fresh MEM (5.5 mmol/L glucose) containing 
10% serum and 37 kBq D-[U-14C]-glucose at 37°C for 2 hr. Production of ™C02 was measured 
as described previously (Ellwood et al., 1993). Data are expressed as nmol glucose 
oxidized/(hour-mg cellular protein). 
f. Transport of 3H-2-D-deoxvolucose (3H-DOG) and 3H-a-aminoisobutvric acid (3H-AIB). 
Cultures of HepG2 and Caco-2 in multiwell dishes were washed twice with HBSS at 37°C and 
incubated with MEM alone or containing the indicated concentrations of the pro-oxidants for 90 
minutes at 37°C. After monolayers were washed twice with HBSS, cultures were incubated at 
37°C with glucose-free MEM containing 3H-DOG (9.25 kBq/mL) and 100 |xmol/L DOG. After 10 
min, cells were washed twice with ice-cold glucose-free MEM containing 100 nmol/L phloretin to 
inhibit 3H-DOG efflux. To measure 3H-AIB uptake, amino acid-free MEM containing 3H-AIB 
(9.25 kBq/mL) with 100 ̂ mol/L AIB at 37°C was added to washed cultures. After 3 min, 
radioactive medium was removed rapidly and monolayers were washed twice with ice-cold 
amino acid-free MEM (2 mL). Cellular material was collected in 1 mL harvest solution. Pilot 
studies showed that uptake of 3H-AIB and 3H-DOG was linear for 4 and 20 min, respectively, 
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using the described conditions. Cellular was determined by liquid scintillation counting. 
Uptake data are expressed as nmol/(min-mg cell protein). 
a. Mitochondrial function. To examine the impact of treatment of cells with the pro-oxidants on 
mitochondrial activity, cells were washed and incubated with MEM alone or containing the 
indicated concentrations of the pro-oxidants for 90 min at 37°C. After washing cultures, MEM 
containing 60 nmol/L 3[4,5~dimethylthiazol-2-yl]-2,5-diphenyltetrazao!ium bromide (MTT) was 
added and cultures were incubated at 37°C. After 30 min, MEM was removed, monolayers were 
washed twice with HBSS, and 1 mL dimethylsulfoxide was added to each well to lyse cells and 
solubilize the reduced MTT crystals. The quantity of reduced MTT was measured 
spectrophotometrically at 560 nm (Scudiero et al., 1988). 
Antioxidant envmes. The cellular activity of selenium-dependent glutathione peroxidase (EC 
1.11.1.9) was determined by addition of aliquots of cell sonicates (5 ̂ L) to cuvettes containing 20 
nL hydrogen peroxide as substrate and 975 nL 50 mmol/L Tris buffer (pH 7.6) with 0.2 mmol/L 
nicotinamide adenine dinucleotide phosphate, 1 mmol/L glutathione (reduced form), 1 unit/mL 
glutathione reductase and 1 mmol/L disodium ethylenediaminetetraacetic acid. Absorption at 340 
nm was monitored for 5 min and data are expressed as nmol H2O2 converted to water/(minmg 
protein) (Lawrence and Burk, 1976). Catalase (EC 1.11.1.6) activity was measured by adding an 
aliquot of cell sonicate (50 |iL) to cuvettes containing 800 nL 50 mmol/L phosphate buffer (pH 
7.0) and 100 nL 20 mmol/L H2O2- The decomposition of H2O2 was monitored by the change in 
absorbance at 240 nm over 3 min (Aebi, 1984). Data are expressed as |imol H2O2 
decomposed/(min-mg protein). The activity of total cellular superoxide dismutase (EC 1.15.1.1) 
was determined by monitoring the inhibition of pyrogallol autoxidation. Aliquots of cell sonicate 
(100 11L) were added to 2.9 mL 50 mmol/L Tris buffer (pH 8.2) containing 1 mmol/L 
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diethyienetriaminepentaacetic acid and 0.2 mmol/L pyrogallol. Absorbance at 320 nm was 
monitored for 5 min. Data are expressed as units/mg protein where 1 unit of SOD activity is the 
amount required to inhibit the oxidation of pyrogallol by 50% (Marklund and Marklund, 1974). 
Glutathione transferase (2.5.1.18) activity was analyzed in a reaction mixture containing 1 
mmol/L 1 -chloro-2,4-dinitrobenzene (25 nL), 1 mmol/L glutathione (25 ̂ L) and 900 nL 100 
mmol/L sodium phosphate buffer (pH 6.5) containing 0.1 mmol/L EDTA (Habig et al., 1974). The 
change in absorbance was monitored at 340 nm for 3 min. Data are expressed as ixmol GSH 
conjugate formed/(min-mg protein). 
Protein determination. Cellular protein was determined as previously described (Ellwood et al., 
1993). 
Statistical analysis of data. Statistically significant differences (p<0.05) were determined using 
either Student's t test or one way ANOVA with post hoc analysis using Tukey's multiple range 
test (SAS Institute, Cary, NC). All experiments were repeated at least twice using triplicate wells 
or flasks for each test variable. Data are expressed as means + SEM. 
RESULTS 
Although somewhat nonspecific, the TBARS assay is useful as an indicator of the extent 
of lipid peroxidation resulting from oxidative stress (Halliweil and Gutteridge, 1989). Therefore, 
the effects of various concentrations of pro-oxidants on the generation of TBARS in HepG2 and 
Caco-2 cultures were examined initially. Concentrations of TBARS in control cell cultures were 
34 + 3 and 50 + 14 pmol/mg protein for HepG2 and Caco-2, respectively. Levels of TBARS in 
cultures of HepG2 increased 14 and 20-fold after exposure to 125 and 250 nmol/L TBHP for 90 
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min, respectively (Fig. 2.1 A). In contrast, exposure of Caco-2 cultures to the same 
concentrations of TBHP elevated levels of TBARS less than 2-fold (p>0.05). Exposure of HepG2 
cultures to 125 and >250 fxmol/L hydrogen peroxide (HPX) increased TBARS levels 
approximately 3 and 7-fold, respectively (p<0.05) (Fig. 2.1B). Levels of TBARS in Caco-2 
cultures were not altered at 125 nmol/L HPX, but increased about 3-fold at >250 ^mol/L HPX. 
TBARS levels increased linearly as the concentration of menadione (MD) increased in HepG2 
cultures; TBARS were 5-fold above the basal level in cultures exposed to 750 |xmol/L MD (Fig. 
2.1C). Caco-2 cultures were more sensitive than HepG2 to lower concentrations of MD with the 
level of TBARS elevated approximately 6- and 8-fold above background after exposure to 125 
and >250 nmol/L pro-oxidant, respectively. The levels of TBARS in cultures of HepG2 and Caco-
2 cultures treated with AAPH increased in direct proportion to the concentration of the stressor 
(Fig. 2.1 D). Concentrations of TBARS were increased 24- and 12-fold above control levels 
(p<0.05) in cultures of HepG2 and Caco-2, respectively, exposed to 100 mmol/L AAPH. These 
observations indicate that the relative susceptibility of HepG2 cultures to lipid peroxidation 
induced by TBHP, HPX and AAPH was greater than that in Caco-2 cultures, whereas Caco-2 
cells exhibited greater sensitivity to MD than HepG2 cells. 
Although increased levels of TBARS in cultures indicate that cellular components were 
peroxidized, it was unknown if the changes reflected a loss of cell integrity and/or function. To 
address these possibilities, cultures were exposed to one concentration of each pro-oxidant that 
had significantly increased the level of TBARS in initial studies, viz., 500 nmol/L for TBHP, HPX 
and MD and 25 mmol/L AAPH. Release of cytoplasmic LDH and cellular51 Cr from HepG2 and 
Caco-2 cells into the medium were used as indicators of membrane integrity. Exposure of 
HepG2 cultures to TBHP, HPX and MD increased medium LDH activity 2.1,2.3 and 1.6-fold, 
respectively (p<0.05) and 51 Cr release 10.6, 3.2 and 5.9-fold, respectively, above control levels 
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Fig. 2.1. Effects of pro-oxidants on levels of thiobarbituric acid reactive substances (TBARS) in 
HepG2 (—O— ) and Caco-2 ( -«r ) cells. 
Confluent cultures were incubated in MEM with or without tert-butylhydroperoxide (panel A), 
hydrogen peroxide (panel B), menadione (panel C) or AAPH (panel 0) at the indicated 
concentrations for 90 minutes at 37°C. Cultures were washed, harvested and analyzed as 
described in METHODS to determine pmol TBARS/mg protein. Data represent means + SE from 
at least two experiments each containing three wells per treatment. The presence of an asterisk 
above the error bar indicates that the level of TBARS in each of the two cell cultures differ 
significantly (p<0.05) from the means of the respective controls after exposure to the given level 
of pro-oxidant. 
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(Table 2.1). In contrast, treatment of Caco-2 cultures with TBHP and MD did not significantly 
(p>0.05) increase LDH release. Exposure to HPX increased 51 Cr release from Caco-2 cells by 
1.5-fold. Exposure of HepG2 and Caco-2 cultures to 25 mmol/L AAPH did not increase LDH 
release. Likewise, apical exposure of Caco-2 monolayers grown on membrane inserts to pro-
oxidants did not significantly (p>0.05) alter the apical to basolateral flux of 14C-mannitol (data 
not shown). 
To determine whether the pro-oxidant-induced biochemical changes were associated 
with altered cellular activity, U-14C-glucose oxidation was examined initally. The basal rates of 
glucose oxidation for control cultures of HepG2 and Caco-2 were 17.2 + 1.7 and 25.0 + 4.0 
nmol/(hrmg protein), respectively. U-14C-Glucose oxidation by HepG2 cultures treated with 500 
nmol/L TBHP (Table 2.2) was only 19% that of the control cultures. Similarly, the rates of U-14C-
glucose oxidation after exposure to HPX, MD and AAPH were decreased to 50, 56 and 79%, 
respectively, that in control cultures of HepG2 (p<0.05). Exposure of Caco-2 cells to TBHP and 
HPX decreased U-14C-glucose oxidation to 89 (p<0.05) and 65% (p<0.05) that by control 
cultures (Table 2.3); this change was less severe than that with HepG2. In contrast, U-14C-
glucose oxidation by Caco-2 treated with MD and AAPH was 40 and 76% that of controls 
(p<0.05), respectively (Table 2.3); these decreases are similar to those observed in cultures of 
HepG2 cells that had been treated similarly (Table 2.2). 
The observed pro-oxidant-induced reductions in glucose oxidation may have been due to 
increased shunting of glucose from the glycolytic to the hexose monophosphate pathway, 
inhibition of cytosolic or mitochondrial enzymes participating in the glucose oxidation, or 
modification of plasma membrane components that are required for the transport of glucose into 
the cell. We assessed the latter possibility by examining the impact of pro-oxidant treatment of 
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TABLE 2.1 
Release of lactate dehydrogenase (LDH) and Chromium (Cr) 
by HepG2 and Caco-2 cells after exposure to pro-oxidants1 
Treatment HepG2 Caco-2 
LDH release 51 Cr release 
iOL\ 
LDH release 
(0/' 
®1Cr release 
i 
CONTROL 1.1+0.1° 2.2 + 0.1d 
\ J 
0.9 +0.1a 2.2 + 0.2b 
TBHP 2.4 + 0.2a 23.4 + 3.8a 0.9 + 0.1a 2.5 + 0.2b 
HPX 2.6 + 0.23 13.0±2.0b 0.9 +0.1a 3.2 + 0.2a 
MD 1.7 + 0.115 7.0 + 2.0° 1.0 + 0.23 2.7 + 0.2b 
AAPH 1.1+0.1° nd 0.8 + 0.1a nd 
1 Cultures of HepG2 and Caco-2 were exposed to MEM alone or MEM containing either 
500 urnol/L TBHP, HPX or MD, or 25 mmol/L AAPH for 90 min at 37°C. LDH activity in aliquots 
of medium and cell sonicates were analyzed as described in Material and Methods to determine 
% LDH released to medium. For51 chromium release studies, cultures were incubated overnight 
(20 hr) with MEM containing 37 kBq 51 Cr prior to exposure to the pro-oxidants. After collecting 
medium, monolayers were washed and harvested. Aliquots of cell sonicates and medium were 
analyzed by gamma ray spectroscopy to determine % 51 Cr released to medium. Data are 
means + SEM for triplicate wells from a representative experiment. Different letters as 
superscripts within a column indicate significant differences (p<0.05) between means. nd=not 
determined. 
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TABLE 2.2 
Oxidation of U-14C-glucose and uptake of 3H-2-deoxyglucose (DOG) and 
3H-<x-aminoisobutyric acid (AIB) by HepG2 cells exposed to pro-oxidants1 
Treatment glucose oxidation DOG transport AIB transport 
nmol/(hrmg protein) nmol/(min mg protein) 
CONTROL 
TBHP 
HPX 
MD 
AAPH 
25.0 + 4.0a 
4.7 + 0.6° 
12.5 + 1.8b 
14.1 +2.1b 
19.8 + 2.3a 
17.3 + 1.5a 
3.8 + 0.5° 
10.7 + 1.2b 
4.6 + 1.5° 
12.0 + 1.5b 
5.0 + 0.13 
0.5 + 0.1d 
3.4 + 0.3° 
2.7 + 0.3° 
4.0 +0.1b 
1 Cultures of HepG2 were exposed to MEM alone or MEM containing either 500 nmol/L TBHP, 
HPX or MD, or 25 mmol/L AAPH for 90 min at 37°C. After removing medium with oxidants, 
monolayers were washed and incubated with MEM containing either U-14C-glucose for 120 min, 
3H-DOG for 10 min, or 3H-AIB for 3 min to determine the effect of treatment on 14C02 
production and the uptake of 3H-DOG or 3H-AIB. Data are means + SEM from triplicate wells or 
flasks from three separate experiments. Different letters as superscripts indicate that significant 
differences (p<0.05) between means within a column. 
TABLE 2.3 
Oxidation of U-1^C-glucose and uptake of 3H-2-deoxyglucose (DOG) and 
3H-a-aminoisobutyric acid (AIB) by Caco-2 cells exposure to pro-oxidants1 
Treatment glucose oxidation DOG transport AIB transport 
nmol/(hrmg protein) nmol/(minmg protein) 
CONTROL 17.2 + 1.7a 17.0 +1.2a 0.28 ± 0.02a 
TBHP 15.3 + 0.5ab 15.0±0.5b 0.30 +0.01a 
HPX 11.2 + 2.5° 15.7+1.8ab 0.30 + 0.03a 
MD 6.9 + 0.2d 3.6 + 0.9° 0.53 ± 0.07b 
AAPH 13.1 +2.3bc 15.8 + 0.9ab 0.31 + 0.04a 
1 Cultures of Caco-2 were exposed to MEM alone or MEM containing either 500 ^mol/L TBHP, 
HPX or MD, or 25 mmol/L AAPH for 90 min at 37°C. After removing medium with oxidants, 
monolayers were washed and incubated with MEM containing either U-^C-glucose for 120 min, 
3H-DOG for 10 min, or 3H-AIB for 3 min to determine the effect of treatment on 14C02 
production and the uptake of 3H-DOG or 3H-AIB. Data are means + SEM from triplicate wells or 
flasks from three separate experiments. Different letters as superscripts indicate that significant 
differences (p<0.05) between means within a column. 
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HepG2 and Caco-2 cultures on the uptake of 3H-2-deoxyglucose (3H-DOG), a nonmetabolizable 
analogue of glucose. The rate of 3H-DOG uptake was only 24,64, 25 and 65% that of control 
cultures after treatment of HepG2 cells with TBHP, HPX, MD and AAPH, respectively (p<0.05). 
In contrast, apical exposure of Caco-2 cultures to TBHP, HPX and AAPH had minimal affect 
(p>0.05) on the rate of 3H-DOG transport (Table 2.3). However, apical exposure of Caco-2 cells 
to MD decreased (p<0.05) the rate of 3H-DOG transport to 25% that of control cultures (p<0.05). 
To determine whether oxidant-induced damage to the process of glucose uptake was 
specific or may have reflected a more general impairment of nutrient transport processes, 
cellular uptake of the amino acid analogue 3H-a-aminoisobutyric acid (3H-AIB) was examined. 
Exposure of HepG2 cells to TBHP, HPX, MD and AAPH reduced the rate of 3H-AIB transport 
(Table 2.2) to 11,68, 54 and 81%, respectively, that of the control (p<0.05). In contrast, 
incubation of Caco-2 cells with TBHP, HPX and AAPH did not significantly alter (p>0.05) the rate 
of 3H-AIB transport (Table 2.3). Moreover, the rate of 3H-AIB uptake by Caco-2 cells treated with 
MD was 1.8-fold higher than that by the control cells (526 + 68 vs. 285 + 19 pmol/mg protein, 
respectively). 
Since many transport processes directly or indirectly require cellular energy, the impact 
of pro-oxidant treatment on mitochondrial activity was measured. Incubation of HepG2 cells with 
TBHP, HPX and AAPH increased the reduction of MTT 4-fold (p<0.05); exposure to MD 
increased MTT reduction 7-fold (p<0.05). Incubation of Caco-2 cells with TBHP and HPX did not 
not alter MTT reduction (p<0.05), whereas exposure to MD and AAPH increased reduction by 2.5 
and 1.3-foid, respectively (p<0.05). Together, these data suggest that mitochondrial activity of 
the cell lines was not impaired by the test conditions and that the decreased rate of DOG and 
AIB transport was not the result of insufficient generation of cellular energy. 
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The ability of a cell type to resist an oxidative challenge depends in part on the activities 
of its antioxidant enzymes. We compared the activities of several key antioxidant enzymes in 
control cultures of HepG2 and Caco-2. The activities of glutathione peroxidase, catalase and 
glutathione transferase were similar in the two cell types (Table 2.4). Total SOD activity was 2.3-
fold (p<0.05) higher in HepG2 than in Caco-2 cells, whereas GSH transferase activity was 1.5 
times (p>0.05) higher in Caco-2 than in HepG2 cells. 
DISCUSSION 
The susceptibility of a tissue to oxidative damage is influenced by the chemical 
characteristics and concentration of the pro-oxidant compound and the duration of exposure, and 
the phenotypic properties of the target cell (e.g., levels of enzymatic and nonenzymatic 
antioxidants and content of unsaturated fatty acids). Because the anatomic location and the 
metabolic activities of the liver and intestinal mucosa result in their exposure to diverse pro-
oxidant species, we compared the relative susceptibilities of commonly used differentiated 
human cell lines from these tissues to several pro-oxidants. More specifically, HepG2 and Caco-
2 cells were selected because confluent cultures of each express many of the phenotypic 
characteristics of hepatocytes and enterocytes, respectively (Knowles et al., 1980, Pinto et al., 
1983, Hidalgo et al., 1989). In general, our results demonstrate that differentiated monolayers of 
Caco-2 intestinal cells are more resistant than HepG2 liver cells to the adverse effects of pro-
oxidants. Apical exposure of Caco-2 cells to 500 nmol/L TBHP and HPX and 25 mmol/L AAPH 
did not significantly alter membrane permeability and nutrient uptake. In contrast, incubation of 
HepG2 cultures with all test pro-oxidants compromised membrane integrity and decreased the 
uptake of glucose and alanine analogues. MD was the one pro-oxidant that increased the levels 
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TABLE 2.4 
Antioxidant Enzyme Activities in HepG2 and Caco-2 Cells1 
HepG2 Caco-2 
glutathione peroxidase [nmol/(min mg protein)] 4.2 + 0.5a 5.8 + 0.3b 
catalase [|imol H2C>2/(min mg protein)! 36.4 + 5.1a 41.5 + 6.2a 
superoxide dismutase (units/mg protein) 2.8 + 0.4a 1.2 + 0.1b 
glutathione transferase [nmol/(min mg protein)] 2.7 + 0.5a 4.0 + 1.5a 
1 Activities of antioxidant enzymes were measured in control cultures of HepG2 and Caco-2 cells 
using standard assays as indicated in the Material and Methods section. Assays were performed 
using at least three monolayers from two different passages for each cell line. Data are means + 
SE and significant differences (p<0.05) in activities between the two cell types are indicated by 
different superscripts. 
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of TBARS and decreased the uptake of glucose and alanine analogues to a greater extent in 
Caco-2 cultures than in HepG2 cultures. Our observations with Caco-2 cells confirm and extend 
the recent report by Baker et al. (1995). These investigators found that apical exposure of Caco-
2 to TBHP (500 |xmol/L) did not significantly alter the integrity of the cell surface, the 
permeability of the monolayer, or production of cellular energy. In contrast, apical exposure to 
500 nmol/L MD adversely affected the plasma membrane permeability and energy production by 
Caco-2 cells. 
Similar to our observations with HepG2 cells, others have reported that exposure of 
isolated rat hepatocytes to organic hydroperoxides (Rush et al., 1985) and HPX (Innes, 1988) 
results in peroxidation of membrane lipids and potentially lethal cellular injury. Additional studies 
have indicated that exposure of rat hepatocytes and HepG2 cells to free radical generating 
quinones, e.g., MD, (Babich and Stem, 1993), and AAPH (Nalini and Balasubramanian, 1991) 
also results in significant cellular damage. 
Although the culture conditions we used for the growth and maintenance of the Caco-2 
and HepG2 cell lines are standard, it is possible that the different composition of the media 
contributed to the differential responses of the cells to oxidants. For example, the formulation of 
the basal media, the percentage and type of sera, and the period between seeding vessels and 
initiating experimental analysis differed for the test cell lines (see Material and Methods). Our 
attempts to address this confounding factor by culturing HepG2 in DMEM with high sera and 
Caco-2 in MEM with 10% FBS were not successful. However, substitution of FBS for the serum 
substitute Fetal Clone II did not influence the relative resistance of Caco-2 cells to oxidative 
stress (data not shown). Another possible factor was that each cell line was used at markedly 
different passage numbers. However, experiments were performed at early passages after 
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arrival of the cell lines from the vendor (ATCC) and are similar to the ranges used by other 
investigators. Recognizing these potential limitations, our aim has been to compare the relative 
susceptibilities of two highly differentiated and widely used human cell lines, viz., HepG2 liver 
and Caco-2 intestinal cells, cultured under typical in vitro conditions to several pro-oxidant 
stressors. 
One alternative possibility for the relative resistance of Caco-2 cells to iron-catalyzed, 
pro-oxidative stress compared to HepG2 cells, is that they may express high levels of antioxidant 
enzymes. Grisham et al. (1990b) compared the activities of antioxidant enzymes in Caco-2 cells 
to those in normal human intestinal tissue and liver. Glutathione peroxidase activity in 
differentiated cultures of Caco-2 and normal colonic epithelium were similar, whereas the 
activities of catalase and superoxide dismutase in Caco-2 cells were significantly lower than in 
normal human colonic epithelium. Moreover, antioxidant enzyme activities in human liver were 
markedly greater than in Caco-2 cells and colonic epithelium. We observed similar activities of 
glutathione peroxidase, catalase and glutathione transferase in HepG2 and Caco-2 cells, but 
higher superoxide dismutase activity in HepG2 cells than in Caco-2 cells. These data suggest 
that the decreased susceptibility of Caco-2 to pro-oxidants as compared to HepG2 cells is not 
simply due to higher activities of antioxidant enzymes in the former. 
The relative resistance of Caco-2 cells to the potentially damaging influence of iron-
catalyzed free radical generators, i.e., TBHP and HPX, is consistent with previous observations 
with homogenates of intestinal mucosa. Balasubramanian et al. (1988) reported that 
homogenates from rats and human small intestinal mucosa were resistant to free-radical induced 
peroxidation in comparison to homogenates from other tissues that were treated identically. 
Similarly, perfusion of intact rat intestine with HPX and xanthine-xanthine oxidase did not induce 
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lipid peroxidation or alter absorptive function (Nalini and Balasubramanian, 1993). In contrast, 
apical perfusion with MD and AAPH induced lipid peroxidation and compromised the 
permeability of the mucosa. This resistance of the intestinal preparations to iron-catalyzed, 
oxidative damage has been associated with the presence of relatively high concentrations of 
non-esterified, monounsaturated fatty acids in the brush border membrane (Diplock et al., 1988; 
Balasubramanian et al., 1989). The addition of oleate to homogenates of extra-intestinal tissues 
from several species, including man, conferred protection against iron-catalyzed damage by pro-
oxidants. It has been suggested that the unsaturated free fatty acids such as oleate complex iron 
at the membrane surface, thereby inhibiting its availability for Fenton-type reactions (Simpson 
and Peters, 1987). Murthy et al. (1988) have reported elevated levels of oleic and palmitoleic 
acids in microsomes isolated from Caco-2 cells, but the levels in the brush border membrane are 
unknown. 
The collective results with Caco-2 cells, intestinal loops and intestinal homogenates 
suggest that the brush border is relatively resistant to iron-catalyzed, oxidant-induced damage. 
Perhaps, the regular presence of dietary pro-oxidants and reactive low molecular weight 
complexes of iron in the intestinal lumen provided a selective pressure for the modification of 
brush border membrane composition, viz., the presence of high levels of monounsaturated free 
fatty acids, to protect against iron-catalyzed oxidative damage. Indeed, Cermak et al. (1993) 
have demonstrated that monolayer cultures of Caco-2 cells are relatively resistant to hydrogen 
peroxide-induced damage even after preincubation with iron(ll)sulfate or hemin. In contrast with 
the reports in which pro-oxidants were added to the apical compartment, Baker and associates 
(1993,1995) have shown that exposure of the basolateral surface of Caco-2 cells to pro-oxidants 
compromises cellular integrity and function. Similarly, excessive production of reactive oxygen 
species by phagocytic cells in the lamina propria can overwhelm the antioxidant capacity of 
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enterocytes, and adversely alter the basolateral surface (Grisham et al., 1990a). The similarity of 
the response of Caco-2 cells and intact intestine to pro-oxidant substances further supports the 
usefulness of this human intestinal cell line as an in vitro model of absorptive epithelial cells. 
Oxidation of U-14C-glucose to was used as an initial indicator of the impact of 
pro-oxidants on cellular metabolism. While exposure to pro-oxidants decreased the apparent 
efficiency of oxidation of labeled U-14C-glucose in both cell lines, the inhibition generally was 
greater in cultures of HepG2 than Caco-2. We found that the decline in production of 14C02 
from U-14C-glucose by pro-oxidant treated cells was correlated with a reduction in the ability of 
the cell to transport the glucose analogue 2-deoxyglucose. It is likely that some of the decrease 
in the rate of U-14C-glucose oxidation by pro-oxidant treated cells also was due to shunting of 
glucose-6-phosphate to the hexose monophosphate pathway (Baker and Baker, 1993; Cepsinkas 
et al., 1994). Pro-oxidant treatment also impaired the uptake of 3H-AIB by HepG2 cells. 
Similarly, Vroegop et al. (1995) recently reported impaired 3H-DOG and 3H-AIB transport in a 
neural hybridoma cell line exposed to several chemical oxidants. This shows that the alteration in 
3H-DOG transport was not specific. Together, these results suggest that the pro-oxidants 
adversely affected the plasma membrane. This conclusion is supported by the normal or 
increased mitochondrial activity in cells after exposure to pro-oxidants suggesting that cell 
energy status was not compromised. 
The excessive generation of free radicals has been implicated in numerous pathological 
conditions in humans. Free radicals or their metabolites react with various cellular 
macromolecules and may damage cell integrity and function. Highly differentiated human cell 
lines provide an important tool for assessing pro-oxidant-induced damage to cells. Our studies 
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indicate that the brush border surface of Caco-2 cells is less susceptible to pro-oxidant-mediated 
damage than the surface of HepG2 cells. 
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CHAPTER III 
P-CAROTENE AND LUTEIN PROTECT THE PLASMA MEMBRANE OFHEPG2 HUMAN 
LIVER CELLS AGAINST OXIDANT-INDUCED DAMAGE 
ABSTRACT 
Numerous epidemiological studies support a strong inverse relationship between 
consumption of carotenoid-rich fruits and vegetables and the incidence of some degenerative 
diseases. One proposed mechanism of protection by carotenoids centers on their putative 
antioxidant activity, although direct evidence in support of this contention is limited at the cellular 
level. The antioxidant potential of p-carotene (BC) and lutein (LUT), carotenoids with or without 
provitamin A activity, respectively, was evaluated using the human liver cell line HepG2. Pilot 
studies showed that 90 min exposure of confluent cultures to 500 nmol/L tert-butylhydroperoxide 
(TBHP) at 37°C significantly (p<0.05) increased lipid peroxidation, cellular leakage of lactate 
dehydrogenase (LDH) and impaired the uptake of ̂ H-a-aminoisobutyric acid and 3H-2-
deoxyglucose. Protein synthesis, mitochondrial activity and glucose oxidation were not affected 
by TBHP treatment suggesting that the plasma membrane was the primary site of TBHP-induced 
damage. Overnight incubation of cultures with >1 (imol/L a-tocopherol protected cells against 
oxidant-induced changes. In parallel studies overnight incubation of HepG2 in medium 
containing micelles with either BC or LUT (final concentrations of 1.1 and 10.9 |xmol/L, 
respectively), the cell content of the carotenoids increased from <0.02 to 0.17 and 1.93 ng/mg 
protein, respectively. Carotenoid loaded cells were partially or completely protected against 
oxidant-induced changes in lipid peroxidation, LDH release and amino acid and deoxyglucose 
transport. These data demonstrate that BC and LUT or their metabolites protect HepG2 cells 
against oxidant-induced damage to the cell membrane. 
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INTRODUCTION 
Carotenoids are naturally occurring pigments in plants that are involved in light 
harvesting reactions and protection of plant organelles against singlet oxygen-induced damage. 
Because free radical-induced damage to mammalian tissues is believed to contribute to the 
aging process and to the development of some degenerative diseases (Canfield et al., 1992), it 
has been proposed that dietary carotenoids serve as antioxidants in tissues (Thumham, 1994). 
This possibility is supported by numerous epidemiologic studies that indicate an inverse 
association between the increased intake of carotenoid-rich fruits and vegetables and the 
incidence of diseases such as cancer (Van Poppel and Goldbohm, 1995). Additionally, in vitro 
studies have demonstrated that carotenoids can inhibit chemically-induced neoplastic 
transformation (Bertram and Bortkiewicz, 1995), induce remission of oral leukoplakia (Garewal, 
1995), quench free radicals such as singlet oxygen (Sies and Stahl, 1995), and modulate 
immune activity (Meydani et al., 1995). 
Possible mechanisms of how carotenoids protect tissues against oxidative damage 
include their antioxidant capacity, interactions with other antioxidants and antioxidant enzymes, 
and conversion to retinoids and apocarotenoids (Canfield et al., 1990). Critical evaluation of the 
antioxidant potential of carotenoids in humans has been hampered in part by the relative lack of 
appropriate animal models. Human cell lines provide a relevant model for investigating 
carotenoid function. The availability of highly differentiated human cell lines with phenotypic 
properties similar to mature hepatocytes is particularly pertinent since the liver actively 
metabolizes drugs and other xenobiotics and generates high levels of free radicals (Moshage 
and Yap, 1992). We selected HepG2 human liver cells as our model because these cells secrete 
plasma proteins and lipoproteins, express an inducible cytochrome P450 system, and respond to 
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hormones and cytokines in a manner similar to normal human liver (Javitt, 1993). The objective 
of the present study was to determine whether pretreatment of HepG2 cells with p-carotene (BC) 
and lutein (LUT), i.e., carotenoids with or without pro-vitamin A activity, respectively, confers 
cytoprotection when cultures are subjected to oxidative stress. 
MATERIALS AND METHODS 
Supplies. All reagents were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise 
noted. D-[U-14C]-glucose (sp. act. 89 MBq/mmol) and D-[6-14C]-glucose (sp. act. 181 
MBq/mmol) and <x-[methyl-3H]-aminoisobutyric acid (sp. act. 252 GBq/mmol) were purchased 
from DuPont/New England Nuclear (Wilmington, DE). 2-Deoxy-D-[2,6-3H] glucose (sp. act. 999 
GBq/mmol) and [4, 5-3H]-leucine (sp. act. 6 TBq/mmol) were obtained from Amersham 
(Arlington Heights, IL). Tissue culture flasks (75 and 25 cm2) and multiwell dishes were obtained 
from Costar Corp. (Cambridge, MA). Purified BC, LUT and echinenone were gifts from Dr. Fred 
Khachik, USDA, Beltsville Human Nutrition Research Center. 
Cell Culture. HepG2 cells were purchased from American Type Tissue Collection (ATCC, 
Rockville, MD) and stock cultures were maintained in T75 flasks. For experiments, cells were 
seeded in multiwell plastic dishes (15 or 35 mm diameter) or T25 flasks and incubated in a 
humidified atmosphere of air/C02 (95:5 v/v) at 37°C. HepG2 cultures (passages 80-90) were 
grown in MEM supplemented with 10% heat inactivated fetal bovine serum (FBS), 1 mmol/L 
pyruvate, 2 mmol/L glutamine, 50 mg/L gentamicin, 0.5 mg/L fungizone and 15 mmol/L N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.0 (complete medium). Medium 
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was replaced every two days and experiments were conducted with cultures at 1-3 days post-
confluency. 
Experiments were initiated by washing confluent cultures twice with Hank's Balanced 
Salt Solution (HBSS) without phenol red at 37°C. Serum-free complete MEM alone (control) or 
containing 500 |xmol/L tert-butylhydroperoxide (TBHP) was added and cultures were incubated at 
37°C for 90 minutes. The indicated conditions for the oxidative stress were selected as 
appropriate after performing pilot studies that examined the effects of varying the concentration 
of TBHP and length of exposure on cell viability, levels of TBARS and LDH release from cell 
monolayers (see below). 
Micellar Preparation and Cellular Uptake of Carotenoids and g-Tocopherol. Carotenoids and dl-
a-tocopherol (a-TC) were delivered to cells as micelles that had been prepared by modification 
of the procedure of El-Gorab and Underwood (1973). All manipulations with carotenoids were 
performed under yellow fluorescent lights to minimize photodecomposition. Appropriate volumes 
of stock solutions of the following compounds in either ethanol, hexane or chloroform/methanol 
were transferred to glass bottles to yield the following final concentrations after dilution with 
complete medium: l-a-phosphatidylcholine (18.7 fimol/L), monoolein (100 fimol/L), taurocholic 
acid (1.7 mmol/L), oleic acid (33.3 ^mol/L) and either BC, LUT or a-TC (15 ̂ mol/L). Pilot 
studies were performed to examine the cytotoxic potential of the micellar preparation at the 
indicated and higher concentrations in which the ratio of the individual components was 
maintained constant. Morphological appearance of the monolayer and release of cytoplasmic 
LDH (see below) were the same in cultures incubated for at least 24 hours in complete MEM 
alone or containing micelles with the components at the final concentrations listed above. 
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However, increasing the quantity of the micellar components by > 50% had an adverse impact 
on the integrity of the monolayer. 
After solvents were evaporated with a gentle stream of nitrogen, complete cell culture 
medium was added to the bottles. Samples were transferred to a water bath sonicator (Sonic 
Systems, Inc., Newtown, PA) at room temperature and sonicated for three cycles of 5 minutes 
each with exchange of bath water between cycles. Samples were filter sterilized (SFCA syringe 
filter with 0.22 î meter pore; Nalgene, Rochester, NY) to remove microcrystalline particles. 
The concentration of micellar a-TC and carotenoids in filtered medium was measured by 
HPLC (Bieri et at., 1979,1985). As indicated in Table 3.1, the filtered micellar preparation 
contained 73% of the LUT and 94% of the a-TC originally added. In contrast, filtered samples 
contained only 7% of the BC added to the original sample, i.e., 1.1 nmol/L BC. Relative 
solubility of BC in the micellar preparation, i.e. 7%, was similar to that reported by Canfield et al. 
(1990), i.e. 4-13%. 
To examine cellular accumulation of the lipophilic test compounds from medium with 
micelles, confluent monolayers of HepG2 were exposed overnight (20 hours) to MEM containing 
the micellar preparation alone or with either BC, LUT or a-TC. After removal of medium, 
monolayers were washed two times with HBSS, collected in 1 mL 0.1 mmol/L phosphate buffer 
containing 10% ethanol with 0.45 î mol/mL butylated hydroxytoluene (BHT) and sonicated 3-5 
seconds using a Sonic Dismembranator at 60% output (Fisher Scientific, Pittsburgh, PA). 
Aliquots (500 (iL) of the sonicate were diluted with ethanol (500 nL) containing echinenone (0.2 
ng/mL) and tocol (25 ^g/mL) as internal standards for analysis of carotenoids and a-tocopherol, 
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TABLE 3.1 
Medium concentrations and accumulation of a-tocopherol, 
p-carotene and lutein by HepG2 cells1 
Post-filtered Medium Cells 
fimol/L nmol/mg protein 
p-carotene 1.1 +0.313 0.32 + 0.07a 
lutein 10.9 +0.17b 3.39 + 0.34k 
a-tocopherol 14.1 + 1.49° 2.58 + 0.35° 
1Aliquots (n=4) of pre- and post-filtered (0.22 ^meter pore) medium were analyzed for 
two separate experiments and cellular content of test compounds was determined for triplicate 
cultures from at least two separate experiments. Cellular levels of a-tocopherol and carotenoids 
in medium containing micelle only were <0.03 and <0.02 ng/mg protein, respectively. Different 
letters as superscripts indicate significant differences (p<0.05) among means within a column. 
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respectively. Samples were extracted into hexane containing BHT (0.45 ^mol/mL), dried under 
nitrogen, reconstituted in the appropriate mobile phase and analyzed by HPLC as described 
below. The concentration of LUT in ceil homogenates was approximately 10 fold that of BC, 
whereas the concentration of a-TC was intermediate between LUT and BC (Table 3.1). 
HPLC Analysis. Carotenoid and a-TC were analyzed independently using HPLC (Hewlett-
Packard, Model HP-1090, Avondale, PA) with a UV/visible dual beam detector with wavelengths 
set at 450 or 292 nm for carotenoids and a-TC, respectively, as described by Bieri et al. (1979, 
1985). The column was a Microsorb-MV 5-^m 25 cm x 0.46 cm diameter C-18 ODS (Rainin, 
Wobum, MA) and was protected by a C18 Adsorbosphere, 5 ̂ m particle size, 0.75 x 0.46 cm 
guard column (Alltech, Deerfield, IL). The mobile phase for the analysis of carotenoids was 
70:20:10 (v/v/v) acetonitrile (with 0.13% (v/v) triethylamine):methylene chloride:methanol 
containing 0.01% (w/v) ammonium acetate. Methanol was used as the mobile phase for the 
analysis of a-TC. The flow rates throughout the isocratic runs were 1.7 and 2.5 mL/min for 
analysis of carotenoids and a-TC, respectively. The column temperature was maintained at 
20°C by using a 40 cm HPLC column water jacket (Alltech, Deerfield, IL) and a constant-
temperature circulator (Fisher model 910; Fisher Scientific, McGaw Park, IL). Data were 
calculated based on the analysis of a series of external standards that were >94% pure as 
verified by HPLC. 
Evaluation of cytoprotective activity of carotenoids and a-TC against TBHP-induced damage 
Thiobarbituric acid reactive substances (TBARS). Peroxidation of membrane lipids was 
estimated by measuring the levels of TBARS in cultures (medium plus monolayer) immediately 
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after a 90 min exposure + 500 nmol/L TBHP by a modification of the method of Buege and Aust 
(1978). Briefly, 100 nL absolute ethanol containing 0.45 nmol/mL BHT was added to wells (9.6 
cm2) containing 2 mL MEM alone or with 500 nmol/L TBHP to quench further oxidation. An 
aliquot (1 mL) of the test medium was transferred to a 5 mL glass screw cap tube and residual 
medium was discarded. The monolayer was washed three times with HBSS at room 
temperature. Cellular material was collected in 1 mL harvest solution containing 10% (v/v) 
ethanol with 0.45 |imol/mL BHT, 3.5 mmol/L sodium dodecyl sulfate, and 1 mmol/L disodium 
ethylenediaminetetraacetic acid. After sonication for 10-20 seconds, one-half of the sample (500 
iaL) was added to the aliquot of medium in the glass tube and the remaining sample was frozen 
at -20°C for protein analysis. Tubes were heated at 95°C for 30 minutes after addition of 2 mL 
TBA solution (26 mmol/L thiobarbituric acid and 920 mmol/L trichloroacetic acid (TCA) in 250 
mmol/L HCI). Samples were cooled in ice, mixed and aliquots were removed and centrifuged at 
16,000 x g for 10 minutes at 25°C. Supemate was analyzed spectrophotometrically at 532 nm. 
Tetramethoxypropane was used as a standard and various concentrations were processed 
identically to samples. Data are expressed as pmol TBARS/mg cell protein. 
Lactate dehydrogenase (LDH) release. The release of the cytoplasmic enzyme LDH (EC 
1.1.1.27) into the medium by HepG2 monolayers during exposure to TBHP was used to assess 
the integrity of the cell membrane. Aliquots of medium were centrifuged for 5 minutes at 700 x g 
at 4°C to remove debris. Monolayers were washed with HBSS (25°C) and collected after 
incubation for 15 minutes in 1 mL 1% (v/v) Triton X-100. Cellular material was sonicated for 3-5 
seconds on ice and the samples were centrifuged at 16,000 x g for 8 minutes at 4°C. LDH 
activity was determined according to Glascott et ai. (1992). The reaction mixture contained 2.8 
mL 0.1 mol/L phosphate buffer (pH 7.5) with 85 |xmol/L NADH, 100 nL 23 mmol/L pyruvic acid, 
and 500 nL supemate from either undiluted medium or cell homogenate that had been diluted 
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1:50 with phosphate buffer. The rate of change in absorption at 340 nm was monitored for 3 
minutes (Beckman DU-640 UV/visible spectrophotometer, Fullerton, CA). The percentage of 
cellular LDH released to the medium was calculated as follows: 
% LDH release = [LDH activity in medium / (LDH activity in medium + LDH activity in cells)] x 100% 
Pilot studies using either various dilutions of supemate from sonicated HepG2 cells that 
were not exposed to TBHP or purified rabbit muscle LOH showed that enzyme activity was not 
altered after exposure to 500 nmol/L TBHP for 90 minutes at 37°C. 
14C-Glucose Oxidation. After incubating cultures with or without TBHP for 90 min, monolayers 
(T25 flasks) were washed twice with HBSS at 37°C. MEM (5.5 mmol/L glucose) containing 10% 
FBS and 37 kBq of either D-[U-14C]- or D-[6-14C]-glucose was added to each flask and cultures 
incubated at 37°C for 2 hr. Production of 14CC>2 was measured as described by Ellwood et al. 
(1993). Data are expressed as nmoles glucose oxidized/(hr-mg cell protein). 
Uptake and Incorporation of 3H-Leucine. After removal of medium + TBHP, monolayers were 
washed twice with HBSS before adding MEM containing 10% FBS and 9.25 kBq [4,5-3H]-
leucine. Cultures were incubated for 60 min at 37°C. Medium was collected and the cell 
monolayer washed twice with ice cold HBSS and harvested as described previously. Cell 
homogenates were sonicated for 3-5 sec, and an aliquot (200 nL) added to cold TCA (306 
mmol/L) to precipitate 3H-protein, vortexed and stored in ice for 15 min. Precipitated material 
was collected by centrifugation for 10 min at 16,000 x g, washed twice with 306 mmol/L TCA and 
resuspended in a small volume of 1 mol/L sodium hydroxide. Aliquots were transferred to vials 
containing 4 mL Ultima Gold scintillation cocktail (Packard, Meriden, CT) and analyzed by liquid 
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scintillation spectrophotometry (Beckman model 6000SE LS counter; Fullerton, CA) to quantify 
3H. TO determine the amount of 3H-protein secreted into the medium, a 200 |xl, sample was 
added to a tube containing an equal volume of water with bovine serum albumin (1 mg/mL) as 
carrier and processed as described for the cell homogenates. The level of acid precipitable 3H in 
cells and medium represents protein synthesized during the labelling period. An additional 
aliquot of cell sonicate also was analyzed to determine total cellular radioactivity. 3H-leucine 
uptake was estimated by adding total cellular 3H and secretory protein 3H. 
Transport of 3H-aminoisobutvric acid (3H-AIB) and 3H-deoxvolucose (3H-DOG). Control and 
TBHP-treated monolayers were washed twice with 2 mL HBSS before adding an amino acid-free 
formulation of MEM without FBS and containing 3H-AIB (9.25 kBq/mL) and 100 n.mol/L AIB. 
Monolayers were incubated for 3 min at 37°C, washed twice with 2 mL amino acid-free MEM at 
0°C and collected in 1 mL harvest solution. To measure 3H-DOG uptake, control and TBHP-
treated cultures were incubated with a glucose-free formulation of MEM without FBS and 
containing 3H-DOG (9.25 kBq/mL) and 100 |xmol/L DOG for 10 minutes. Radiolabeled medium 
was removed and monolayers were washed twice with 2 mL ice cold, glucose-free MEM 
containing 200 pjnol/L phloretin to inhibit DOG efflux. Pilot studies showed that uptake of 3H-AIB 
and 3H-DOG were linear for 4 and 20 minutes, respectively, using the described conditions. 
Cellular 3H was measured as described above and data are expressed as nmol/(minmg 
protein). 
Mitochondrial Activity. To examine the impact of treatment of cells with TBHP on mitochondrial 
activity, control and treated cells were washed twice with HBSS before the addition of serum-free 
MEM containing 60 nmol/L 3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) for 
30,60 or 90 minutes. At indicated times, MEM was removed from replicate wells and dimethyl 
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sulfoxide (1 mL) was added to lyse cells and solubilize reduced crystals of MTT. After mixing for 
5 minutes, the increase in optical density of reduced MTT was determined at 560 nm by 
UV/visible spectrophotometry (Scudiero et al., 1988). 
Protein. Cellular protein was quantified as previously described (Ellwood et al.,1993). 
Statistics. Data were analyzed using either Student's t test or one way ANOVA with post hoc 
analysis using Tukey's multiple range test to determine statistically significant differences 
(p<0.05; SAS Institute, Cary, NC). All experiments were repeated at least twice using triplicate 
cultures for each test parameter. Incubation of HepG2 cultures with (3-carotene, lutein and a-
tocopherol independent of pro-oxidant exposure did not have a statistically significant effect on 
any of the parameters used (see Materials and Methods). Consequently, data are expressed as a 
comparison of response of TBHP exposure versus control cultures not exposed to the oxidant. 
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RESULTS 
Prior to evaluating the cytoprotective influence of carotenoids against pro-oxidant injury, 
it was necessary to establish a positive control for the protection of HepG2 cultures against 
TBHP-induced damage. Monolayers were incubated overnight in complete medium containing 
micelles with increasing concentrations of a-TC to examine the relationship between cellular 
content of a-TC and susceptibility to TBHP-induced injury. Cellular a-TC was increased 
significantly when the medium was supplemented with >3 jimol/L a-TC (Fig. 3.1, upper panel) 
and was correlated positively (r=0.84) with medium a-TC between 1-30 nmol/L. The level of 
TBARS was measured to assess peroxidation of membrane polyunsaturated fatty acids in 
control and TBHP-treated samples. TBHP-induced elevation of TBARS in cultures was 
attenuated by pre-treatment of monolayers with medium containing 1-30 |imol/L a-TC (Fig. 3.1, 
lower panel). TBARS levels in TBHP-treated cultures were inversely correlated (r= -0.86) with 
cellular levels of a-TC. To determine if the increase in TBARS was associated with a loss of 
membrane integrity, release of LDH into medium was measured. Exposure to TBHP increased 
release of LDH from a background level of 2.4 + 0.2% to 12.0 + 1.2 % (Fig. 3.1, lower panel). 
Pretreatment of cultures with as low as 0.3 nmol/L a-TC significantly decreased TBHP-mediated 
release of LDH from cells, whereas overnight incubation in medium containing >3 nmol/L a-TC 
completely blocked TBHP-mediated release of LDH. Addition of micelles alone to complete 
MEM did not affect the increases in TBARS levels and LDH release in response to exposure to 
TBHP. In subsequent studies, cultures were incubated overnight in medium containing 14 ^mol/L 
a-TC, since this concentration represents the lower range for normal human plasma, i.e., 15-40 
nmol/L (Keaney and Frei, 1994). 
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Figure 3.1. Accumulation and cytoprotective influence of a-TC in HepG2 cells incubated with 
supplemental a-TC. 
Upper panel. Cultures were incubated for 20 hr with increasing concentrations of a-TC delivered 
in micelles before analyzing the cellular content of the antioxidant. Cultures incubated in 
complete medium with micelles but no supplemental a-TC contained 0.26 + 0.12 nmol a-TC/mg 
protein. Lower panel. After loading cells with a-TC, replicate cultures were treated with 500 
nmol/L TBHP for 90 min at 37°C before analyzing the levels of TBARS (open squares) and 
release of cytoplasmic LDH (closed squares). The levels of TBARS and LDH release in control 
cultures, i.e., not supplemented with a-TC or exposed to TBHP, were 0.15 + 0.03 nmol/mg 
protein and 2.4 + 0.2%, respectively. Data are the means ± SE from a representative experiment 
with at least three wells for each treatment. Significant differences (p<0.05) between groups 
treated with a-TC or micelles only are indicated by asterisks above the error bars. 
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Next, the impact of pre-treatment of cultures with either BC or LUT on susceptibility to 
pro-oxidant damage was determined. Overnight incubation in medium containing micelles with 
either BC (1.1 nmol/L), LUT (10.9 (imol/L) or a-TC (14.1 |imol/L) did not significantly alter basal 
levels of TBARS or LDH release in cultures treated with micelles only (data not shown). Prior 
exposure to medium containing BC and LUT attenuated TBHP-induced elevations in both 
TBARS (Fig. 3.2) and LDH release (Fig. 3.3), although the degree of protection conferred by the 
carotenoids was significantly less (p<0.05) than that observed for cultures that had been 
incubated with supplemental a-TC. 
To assess whether the oxidant-induced biochemical changes outlined above were 
associated with alterations in cellular activities, the uptake and incorporation of 3H-leucine into 
acid precipitable protein was compared in control and TBHP-treated cultures. Exposure of 
cultures to TBHP decreased cellular accumulation of 3H-leucine in 60 min by 52% (15.8 + 0.2 
vs. 7.6 + 0.4 nmol/mg protein for control and TBHP-treated cells, respectively; p<0.05). 
Overnight incubation of HepG2 with micelles containing BC, LUT and a-TC completely protected 
cells against TBHP-induced reduction of 3H-leucine accumulation (Table 3.2). The percentage of 
cellular 3H present in the acid insoluble fraction was similar in both control and TBHP-treated 
cultures suggesting that protein synthesis was not significantly altered by exposure to the pro-
oxidant. These data suggested that TBHP impaired amino acid uptake. To address this 
possibility, the unidirectional transport of the non-metabolizable amino acid analogue a-
aminoisobutyric acid (3H-AIB) was measured in control and TBHP-treated cultures. As shown in 
Figure 4, treatment of cultures with TBHP decreased 3H-AIB uptake to 16% that of control (0.71 
+ 0.04 vs. 4.42 + 0.13 nmol/(min mg protein), respectively; p<0.05). Overnight incubation of 
cultures in medium containing BC and LUT attenuated the impact of TBHP treatment on 3H-AIB 
transport; cellular uptake of 3H-AIB by BC and LUT treated cultures exposed to TBHP was 33 
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Figure 3.2. Preincubation with a-TC, BC and LUT attenuates TBHP-induced generation of 
TBARS in HepG2 cultures. 
Cultures were incubated overnight in medium containing micelles alone or with either a-TC (14.1 
fxmol/L), BC (1.1 nmol/L) or LUT (10.9 nmol/L) as indicated in Table 3.1. After washing the 
monolayer, cultures were exposed to TBHP for 90 min and TBARS levels were measured as 
described in Materials and Methods. Data represent means + SE for at least two separate 
experiments performed in triplicate. Different letters above the error bars indicate significant 
(p<0.05) differences between means of treatment groups. 
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Figure 3.3. Preincubation with a-TC, BC and LUT decreases TBHP-induced release of 
cytoplasmic LDH in HepG2 cultures. 
After overnight incubation with carotenoids or a-TC as described in the legend to Table 3.1, 
cultures were exposed to TBHP for 90 min and LDH release was determined. Data are means + 
SE from at least two separate exeriments performed using triplicate wells. Different letters above 
the error bars indicate the means of the treatment groups differ significantly (p<0.05). 
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TABLE 3.2 
Effect of exposure to TBHP on accumulation and incorporation of 3H-Leucine in 
cultures of HepG2 pretreated overnight with a-tocopherol, p-carotene and lutein1 
Treatment -TBHP +TBHP 
Cellular accumulation of 3H-Leucine 
micelles only 
+p-carotene 
-•-lutein 
+a-tocopherol 
Incorporation of 3H-Leucine into protein 
micelles only 
+p-carotene 
-Hutein 
+a-tocopherol 
nmol/mg protein 
202 + 3 
195+17 
190 + 21 
217+19 
110 + 5* 
199 + 12 
172 + 7 
219 + 12 
% acid ppt. cellular 3H 
36.3 + 1.6 
44.6 + 8.3 
41.3 + 2.7 
34.9 + 1.4 
35.5+1.3 
41.2 + 3.4 
37.9 + 2.2 
31.1 +3.5 
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1 Cultures were incubated overnight in complete medium containing micelles with or 
without either p-carotene (1.1 ixmolL), lutein (10.9 nmol/L.) or a-tocopherol (14.1 nmol/L). 
Medium was removed and monolayers were washed with HBSS before addition of MEM +500 
(xmol/L TBHP and incubated for 90 min at 37°C. After washing the monolayers, complete MEM 
containing 9.25 kBq [4,5-3H]-leucine was added and cultures were incubated for 1 hr at 37°C. 
Total cellular 3H and the percentage of cellular 3H incorporated into acid precipitable (ppt.) 
protein were determined as described in Materials and Methods. Data represent means +SE for 
at least two experiments with three replicate wells per experiment. The presence of an asterisk 
as superscript indicates that means for control and TBHP-treated cultures differ significantly 
(p<0.05). 
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Figure 3.4. Pretreatment with <x-TC, BC and LUT attenuates oxidant-induced reduction of 3H-AIB 
transport in HepG2 cells. 
Cultures were incubated overnight as described in Table 3.1. After 90 min exposure to TBHP, 
cultures were pulsed with MEM containing ®H-AIB (18.5 kBq/well) for 3 min and uptake of the 
radiolabel was determined. Data represent means + SE from at least three separate experiments 
each performed in triplicate. Different letters above the error bars indicate significant differences 
(p<0.05) between the means of the treatment groups. 
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and 60%, respectively, that of the control (p<0.05). Prior supplementation of cultures with a-TC 
was more effective than the carotenoids at blocking TBHP-mduced damage to the 3H-AIB 
transport process. 
In a parallel series of studies, the impact of oxidant exposure on glucose utilization by 
HepG2 cells was examined. Cultures incubated with uniformly labeled (U)-14c-glucose after 
exposure to TBHP generated only 56% as much 14C02 as controls (p<0.05). Because 
mammalian cells respond to many toxicants by increasing the activity of the hexose 
monophosphate pathway, the apparent reduction in glucose oxidation caused by TBHP may 
have reflected altered utilization of the substrate rather than impaired glucose oxidation. 
Therefore, we next compared 6-14C-glucose oxidation by control and TBHP treated cultures 
(Figure 3.5), since the production of 14CC>2 from this compound is primarily due to glycolytic 
activity (Katz and Wood, 1960). Overnight incubation of cultures in medium containing BC, LUT 
and a-TC completely protected cells against the TBHP-mediated reduction in 6-14C-glucose 
oxidation. Since TBHP decreased 3H-AIB uptake (see above), it was necessary to consider 
whether the apparent decrease in 14C-glucose oxidation in TBHP-treated cells might reflect 
impaired transport of glucose across the plasma membrane, i.e., decreased cellular acquisition 
of the radiolabel. Similar to results for the oxidation of 6-14C-glucose, 3H-DOG uptake by TBHP-
treated cultures was only 55% that of the control (Figure 3.6). Overnight incubation of cultures in 
medium containing BC, LUT and a-TC completely protected cells against the adverse effects of 
TBHP on 3H-DOG transport. These data suggest that glucose transport, but not its utilization, 
was adversely affected by treatment of cells with TBHP. 
Since nutrient and electrolyte transport processes are often energy-dependent, the 
mitochondrial activity of control and TBHP-treated HepG2 cultures was examined. Exposure of 
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Figure 3.5. a-TC, BC and LUT protects HepG2 cells against TBHP-mediated suppression of 
glucose oxidation. 
Cultures were incubated overnight as outlined in Table 3.1. After exposure to TBHP, production 
of ^C02 was measured in cultures incubated for 2 hr with 6-^C-glucose. The data represent 
means + SE from at least three experiments performed in triplicate. An asterisk above the error 
bar indicates that values for the treatment groups differ significantly (p<0.05). 
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+TBHP 
Figure 3.6. TBHP does not impair 3H-DOG transport by HepG2 cells pretreated with a-TC, BC 
andLUT. 
Cultures were incubated overnight as described in Table 3.1. Cultures were exposed to pro-
oxidant and subsequently incubated for 10 min in MEM containing ̂ H-DOG to determine cellular 
uptake of the glucose analogue. Data represent means ± SE from at least three experiments 
each performed in triplicate. Letters above the error bars indicate significant differences among 
the means of the treatment groups. 
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cells to TBHP did not decrease mitochondrial activity as assessed by metabolic reduction of the 
tetrazolium dye MTT (data not shown). 
68 
DISCUSSION 
Our primary goal was to evaluate the cytoprotective influence of BC and LUT, 
carotenoids with and without provitamin A activity, respectively, against oxidative stress in a 
highly differentiated human liver cell model, viz., HepG2 cells. The data demonstrate that 
preincubation of cells in medium containing micellar preparations of BC and LUT provided cells 
with partial to full protection against oxidant-mediated changes in plasma membrane integrity 
and the uptake of analogues of glucose and alanine. This confirms and extends the observations 
of several other investigators who have examined the impact of carotenoid treatment on the 
status of animal fibroblast cell lines. Zhang et al. (1991) found that long term treatment with 
carotenoids (3 ̂ mol/L), including BC and LUT introduced in acetone and tetrahydrofuran, 
respectively, decreased levels of TBARS in cultures of 10T1/2 mouse embryo fibroblasts. 
Similarly, Franke et al. (1995) reported that treatment with <10 nmol/L BC (ethanol vehicle) 
decreased lipid peroxidation in 10T1/2 cell cultures exposed to a-linolenic acid. Lawlor and 
O'Brien (1995a, 1995b) also have shown that <10 |xmol/L BC and astaxanthin delivered in 
ethanol protected chick embryo fibroblasts against paraquat-induced changes in the activities of 
the antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase. Our 
conclusion that BC and LUT protected HepG2 cells against oxidative damage is further 
supported by demonstration that preincubation of HepG2 cells in medium containing as low as 1 
nmol/L a-TC conferred partial resistance against TBHP-mediated elevation of TBARS and LDH 
release. a-TC is recognized as one of the most efficient lipophilic antioxidants and protects cell 
membranes from peroxidative damage (Packer, 1991). These findings agree with previous 
reports that addition of < 1 nmol/L a-TC to medium protected rat hepatocytes (Glascott et al., 
1992) and HepG2 cells (Turley and Brewster, 1993) against oxidant-induced damage. 
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Our original objective was to compare the relative effectiveness of the two carotenoids to 
one another and to a-TC. We had hoped to incubate cultures in medium with similar 
concentrations, i.e., 15 fxmol/L of carotenoids and a-TC. However, HPLC analysis of the 
concentration of the test compounds in filtered medium revealed that BC was poorly solubilized 
by micelles. As shown in Table 3.1, the final concentration of BC in filtered medium was only 1.1 
nmol/L, whereas the concentrations of LUT and a-TC were 10 and 14-fold higher, respectively. 
The cellular concentration of BC was about 10% that of LUT, suggesting that accumulation of 
these carotenoids were proportional to their levels in medium. Canfield et al. (1990) reported that 
the efficiency of BC incorporation into micelles was maximum at 15 nmol/L, and that the relative 
amount of BC incorporated into micelles varied between 4 and 13% of the initial concentration. 
Similarly, Levin and Mokady (1995) reported that the maximum solubility of BC in micelles was 
14 nmol/L and also that the isomer composition of BC mixtures affected the total amount of BC 
incorporated. It is likely that the low solubility of BC in our system was due in part to the need to 
decrease the concentrations of the components used for the preparation of micelles to prevent 
cytotoxicity. Also, taurocholate was the only bile acid in our preparation, whereas the formulation 
used by Canfield et al. (1990) contained taurocholate and 5 additional bile salts. Exclusion of the 
other bile acids may have affected the efficiency of BC incorporation, since the types and 
relative quantities of lipids will influence the structure and size of micelles (El-Gorab and 
Underwood, 1973). Additionally, we used a relatively short time for solubilization of these 
compounds into micellar preparations and filter sterilized (0.22 ixmeter pore) the material before 
use, thereby removing microcrystalline particles. 
Both BC and LUT attenuated, but did not prevent, TBHP-induced increases in TBARS 
and LDH release. Pre-treatment with a-TC prevented the enhanced leakage of cytoplasmic LDH 
and significantly reduced (p<0.05) the rise in TBARS after exposure to TBHP. However, various 
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factors preclude direct comparison of the antioxidant potency of the carotenoids and a-TC in our 
model. First, as discussed above, the final concentrations of BC, LUT and a-TC in medium and 
cells differed. Second, cellular concentration by itself does not provide insights about subcellular 
distribution and spatial orientation of the carotenoid within membranes (Britton, 1995). Third, we 
did not consider the types or concentrations of carotenoid metabolites present in the cells. 
Khachik et al. (1995) have discussed the potential role of carotenoid metabolites as mediators of 
the biological properties that are normally associated with their parent compounds. Finally, sites 
of toxicant-induced damage are likely to be influenced by both the chemical properties of the 
free radical produced and the phenotypic characteristics of the cell. Therefore, specific 
conditions will influence the effectiveness of antioxidants as cytoprotective agents against free 
radical-induced damage. 
One proposed mechanism of damage by the pro-oxidant TBHP is the initiation and 
propagation of lipid peroxidation of polyunsaturated fatty acids in the plasma membrane. 
However, TBHP or its metabolites may also interact with and damage various intracellular 
processes (Aw and Rhoads, 1994). Olson (1994) has argued that evaluation of regulated cellular 
activities provides greater sensitivity for detecting oxidative insult than simply monitoring the loss 
of barrier integrity or lethality. Therefore, we monitored the impact of TBHP exposure on the 
ability of cultures to incorporate 3H-leucine into protein. Exposure to the pro-oxidant decreased 
cellular accumulation of the amino acid, but did not alter its relative incorporation into protein. 
This suggested that TBHP-induced damage was localized to the plasma membrane in our 
model. In support of this possibility, 3H-AIB uptake was suppressed by 84% after TBHP 
treatment. It is noteworthy that 3H-leucine and 3H-AIB uptake are mediated by different amino 
acid transporters, viz., systems L and A, respectively (Goenner et al., 1992), suggesting that 
TBHP adversely affected amino acid transporters. TBHP also has been reported to alter the 
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transport of ions in several cell types. Srivastava et al. (1989) found that TBHP treatment 
increased sodium entry into myocytes by altering Na+-channels through increased lipid 
peroxidation. Elliott and Koliwad (1995) found that exposure of endothelial cells to TBHP 
markedly inhibited agonist-stimulated uptake of Ca^+ across the plasma membrane, and that 
this impairment appeared to be due to an alteration in the membrane transport protein rather 
than to lipid peroxidation. TBHP-mediated reduction in 3H-AIB transport may result from altered 
membrane fluidity, conformational changes of the transporter due to peroxidation of membrane 
lipids in the local environment, or oxidative modification of the transporter protein itself. Since 
BC, LUT and a-TC all significantly (p<0.05) attenuated the impact of TBHP exposure on 3H-AIB 
uptake by HepG2 cells, it appears that these compounds or their metabolites conferred partial or 
complete protection against oxidant-induced alterations in the plasma membrane. This protective 
influence was not limited to amino acid transporters, since the carotenoids also prevented TBHP-
induced impairment in 3H-DOG transport. These data agree with reports by Vroegop et al. 
(1995) who recently reported marked impairment of 3H-AIB and 3H-DOG transport in neuron-
derived hybridoma cells exposed to the lipophilic pro-oxidant cumene hydroperoxide. 
Transport activities are generally energy-dependent processes requiring ATP for function 
of the Na+/Kf pump, maintenance of electrochemical gradients and proper function of the 
transporters. Exposure of HepG2 cells to TBHP did not affect mitochondrial activity. Similarly, 
cumene hydroperoxide did not adversely affect mitochondrial function in neural hybridoma cells 
(Vroegop et al., 1995). Thus, impaired transport of 3H-AIB and 3H-DOG by TBHP-treated 
HepG2 cells appears to be due to direct damage of the cell surface rather than a limitation in 
energy required to maintain nutrient transport. 
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In summary, both BC and LUT partially or completely protected HepG2 human liver cells 
against free radical-mediated damage as assessed by a panel of biochemical and functional 
indicators. The protective influence of LUT indicates that the carotenoids do not need to be 
converted to retinoids for occurrence of this phenomenon. It is unknown if the parent compounds 
and/or their metabolites are the species that act as antioxidants within cells. The implications of 
these findings are that increased consumption of carotenoid-rich fruits and vegetables may 
contribute to the protection of human cells against the adverse effects of free radicals on cellular 
integrity. 
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CHAPTER IV 
HUMAN LIPOPROTEINS AS A VEHICLE FOR THE DELIVERY OF p-CAROTENE AND 
a-TOCOPHEROL TO HEPG2 CELLS 
ABSTRACT 
Highly differentiated human ceil lines represent a useful in vitro model for the study of 
carotenoid uptake, metabolism and function. However, research using cell culture systems has 
been hindered due to the marked hydrophobic  ̂of these compounds in aqueous systems and 
the difficulty of presenting carotenoids in a bioavailable form. These compounds are usually 
introduced into tissue culture media either in organic solvents or as micelles, whereas 
carotenoids are localized in lipoproteins in plasma. Initially, the stability of p-carotene and a-
tocopherol in micelles and human lipoproteins under standard tissue culture conditions was 
compared. After filtration (0.22 (xmeter pore) and overnight incubation of p-carotene and a-
tocopherol in serum-free medium without cells, recovery of p-carotene and a-tocopherol was 27 
+ 2 and 73 + 2%, respectively. In contrast, recovery of p-carotene and a-tocopherol was > 88% 
when medium containing total lipoproteins (1 mg/mL) isolated from p-carotene supplemented 
individuals (60 mg/d for 4 weeks) was incubated overnight without cells. The marked loss of p-
carotene from medium containing micellar preparations was the result of oxidative modification, 
since p-carotene recovery was increased considerably by inclusion of a-tocopherol in micelles. 
Overnight incubation of confluent HepG2 cultures with lipoproteins containing 1 nmol/L p-
carotene or a-tocopherol increased cellular levels from < 0.02 to 0.17 and < 0.03 to 0.42 ng/mg 
protein, respectively. Cellular accumulation of p-carotene and a-tocopherol was proportional to 
the concentrations of the lipophilic compounds (r=0.94 for p-carotene and 0.74 for a-tocopherol) 
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Similarly, cellular levels of p-carotene and a-tocopherol were positively correlated with the 
concentration of the compounds in medium containing either low density lipoprotein (r=0.85 for 
p-carotene; r=0.74 for a-tocopherol) or high density lipoproteins (r=0.82 or p-carotene and r=0.66 
for a-tocopherol). These data show that lipoproteins represent a stable vehicle for delivery of p-
carotene and a-tocopherol to HepG2 human liver cells. 
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INTRODUCTION 
Dietary carotenoids are absorbed into the blood via the lymphatic system and 
transported in circulation by plasma lipoproteins (Erdman et al., 1993). LDL carries 55-80% of 
the total carotenoids in the plasma of healthy subjects (Clevidence and Bieri, 1993). For 
example, Johnson and Russell (1992) reported that 79, 8 and 12% of the p-carotene (BC) in 
human serum was present in the low density lipoprotein (LDL), high density lipoprotein (HDL), 
and very low density lipoprotein (VLDL) fractions, respectively. The types and quantities of 
carotenoids present in many human tissues generally are reflective of those in plasma, 
suggesting that there is effective transfer of carotenoids from plasma lipoproteins to tissues 
(Clevidence and Bieri, 1993). 
Detailed investigation of the transport and tissue specific accumulation of carotenoids 
has been hampered somewhat by the lack of appropriate animal models. Human and animal 
cells appear to represent useful models for studying the accumulation and metabolism of 
carotenoids. However, the extreme hydrophobicity and relative instability of carotenoids in air 
makes their delivery to cultured cells problematic. Various investigators have added carotenoids 
to tissue culture media using organic solvents (e.g., tetrahydrofuran, ethanol and dimethyl 
sulfoxide), liposomes, water miscible beadlets and micelles as vehicles (Cooney et al., 1993). 
Vehicle alone is usually added to replicate cultures to monitor potential cytotoxicity of the carrier. 
However, the long-term solubility and stability of the test carotenoids during incubation using 
standard tissue culture conditions has received minimal attention. Moreover, it is not clear if the 
carotenoids partition into lipoproteins, their physiologic carrier, in serum-containing tissue culture 
medium when introduced in the vehicles indicated above. In the present study, we assessed the 
influence of standard tissue culture conditions on the stability of BC and a-tocopherol (a-TC) 
added to serum-free medium as either micelles or lipoproteins. We also examined the 
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effectiveness of lipoproteins as vehicles for the delivery of BC and a-TC to HepG2 human liver 
cells. This highly differentiated cell line was selected as the in vitro model because it secretes 
plasma proteins, expresses an inducible cytochrome P450 system, and responds to hormones 
and cytokines in a manner similar to normal human liver (Javitt, 1990; Knowles et al., 1980). 
Moreover, HepG2 cells possess specific receptors for apolipoproteins B and E, catabolize LDL, 
HDL and apoprotein E-containing particles, and synthesize VLDL, LDL and HDL (Javitt, 1990). 
MATERIALS AND METHODS 
Supplies. All chemicals were obtained from Sigma Chemical Co. (St. Louis, MO) unless 
otherwise stated. Tissue culture flasks (T75) and multiwell dishes (35 mm diameter) were 
obtained from Costar Corp. (Cambridge, MA). Capsules containing synthetic p-carotene (30 
mg/capsule) and placebos were provided by Hoffman-LaRoche (Nutley, NJ). 
Subjects. Five healthy, normolipemic adult males (25-47 yrs of age) in our laboratory 
volunteered to ingest either a BC supplement (60 mg/d; n=2) or placebo (n=3) at 2 meals per 
day for 4 wk. Blood samples were collected by a trained phlebotomist at various times during and 
after the supplementation period to prepare lipoprotein fractions containing different levels of p-
carotene. Two independent supplementation studies were conducted with an 8 wk washout 
period to allow plasma BC levels of BC-supplemented subjects to return to baseline levels. In the 
first study, blood samples were collected at the beginning and the end of the 4 wk 
supplementation period from placebo and p-carotene supplemented subjects. Additional blood 
samples were collected at 2 and 4 weeks post-supplementation from BC-supplemented subjects 
to obtain total lipoproteins with different concentrations of BC. In the second study, blood 
samples were collected at the beginning and the end of the 4 wk supplementation period and at 
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2 wk post supplementation. In this study, samples of total lipoproteins were also fractionated to 
obtain LDL and HDL. 
Isolation of lipoproteins. Blood was collected by venipuncture into vacutainer tubes containing 
Najj-EDTA (1 mmol/L) as a preservative after an overnight fast. Plasma was separated from 
whole blood by centrifugation at 1,500 x g for 25 min at 4°C and transferred to glass vials using 
glass Pasteur pipets. Lipoproteins were isolated as described by Lanningham-Foster et al. 
(1995). Briefly, the density of plasma (d=1.006 g/mL) from each subject was elevated to 1.21 
g/mL by addition of solid potassium bromide (0.3265 g/mL). Aliquots of plasma (1.8 mL) were 
transferred to polyallomar tubes for the Beckman 50.3 Ti rotor and overlaid with 4.3 mL of a 
sodium chloride solution (d=1.006 g/mL) containing 0.01% sodium EDTA. To flotate lipoprotein 
particles, tubes were centrifuged for 40 hr (Beckman L7-65 ultracentrifuge, Fullerton, CA) at 
114,000 x g at 18°C with automatic soft-start and braking disengaged at 800 rpm. After recovery 
of the total lipoprotein fraction (LP) that was essentially free of albumin, the volume was 
readjusted to a final density of 1.21 g/mL This preparation (1.8 mL in 50.3 Ti rotor tube) was 
overlaid with sodium chloride solution (d=1.006 g/mL) and centrifuged for 4 hr as described 
above. After ultracentrifugation, the HDL and LDL lipoprotein bands were readily visualized by 
the presence of carotenoids in the fractions. The VLDL band was visualized as the top white 
layer in the centrifuge tube. The lipoprotein fractions were collected using syringe/needle 
assemblies, transferred to glass tubes and stored in the dark under a nitrogen blanket at 4°C for 
a maximum of two wk. Prior to use in experiments, KBr was removed by passing the lipoprotein 
sample through a gel filtration column (Econo-Pac 10DG, Bio-Rad, Hercules, CA) packed with a 
polyacrylamide gel matrix with a 6 kDa pore size and equilibrated with phosphate buffered 
saline, pH 7.5. Protein levels of total lipoprotein (LP), LDL and HDL fractions were measured by 
the Lowry procedure as modified by Markwell et al. (1981). 
78 
Cell culture. HepG2 cells were purchased from American Type Culture Collection (ATCC, 
Rockville, MD) and stock cultures were maintained in T75 flasks. For experiments, cells were 
seeded in multiwell plastic dishes (35 mm diameter) and incubated in a humidified atmosphere 
of air/C02 (95:5 v/v) at 37°C. HepG2 cultures (passages 80-90) were grown in MEM 
supplemented with 10% fetal bovine serum (FBS), 1 mmol/L pyruvate, 2 mmol/L glutamine, 50 
mg/L gentamicin, 0.5 mg/L fungizone and 15 mmol/L N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid (HEPES), pH 7.0 (complete medium). Medium was replaced every two days 
and experiments were conducted with cultures at 1-3 days post-confluency. 
Micellar preparations of BC and a-TC. Appropriate volumes of stock solutions of the following 
compounds in either ethanol, hexane or chloroform/methanol were transferred to glass bottles to 
yield the following final concentrations after dilution with complete medium: l-a-
phosphatidylcholine (16.7 |imol/L), monoolein (100 nmol/L), taurocholic acid (1.7 mmol/L), oleic 
acid (33.3 ̂ mol/L) and either BC or a-TC (15 nmol/L). In one study, micelles containing both BC 
and a-TC were prepared. After solvents were evaporated with a gentle stream of nitrogen, 
complete cell culture medium was added to bottles which were then transferred to a water bath 
sonicator (Sonic Systems, Inc., Newton, PA) at room temperature and sonicated for three cycles 
of 5 min each. Samples were filter sterilized (SCFA syringe filter with 0.22 (xmeter pore, 
Nalgene, Rochester, NY) before incubating overnight in plastic multiwell dishes. In other studies 
(Chapter 3), it was shown that the described micellar preparation did not alter the morphological 
appearance of the monolayer or compromise the integrity of the cell surface. 
In vitro stability of BC and a-TC. The influence of standard cell culture conditions on BC and a-
TC was assessed by overnight incubation of complete medium containing either micellar 
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preparations or total lipoproteins (1 mg protein/well) in tissue culture dishes without cells. The 
lipoprotein fraction was prepared from BC-supplemented subjects (n=2 subjects) during each of 
the two trial periods. Aliquots of medium containing either micelle or lipoprotein were extracted 
and analyzed as described below immediately after filter sterilization and incubation for 20 hr at 
37°C in a humidified atmosphere of air/C02 (95:5 v/v). Each test sample was incubated in 
triplicate wells. 
Cellular accumulation of BC and a-TC. Carotenoids and a-tocopherol were introduced into 
confluent cultures of HepG2 cells by using lipoproteins as vehicles. Experiments were initiated 
by overnight incubation of confluent cultures in serum-free medium containing 0.1% ITS (insulin, 
transferrin and selenium; Collaborative Research, Bedford, MA) to increase expression of 
lipoprotein receptors on the cell surface (Javitt, 1990). Monolayers were washed and incubated 
with 1 mL serum-free MEM containing 0.1% ITS (v/v) and either the indicated lipoprotein fraction 
or PBS vehicle (control). The concentrations of total LP, HDL and LDL were 1.0,1.0 and 0.5 mg 
protein/mL, respectively. The lower concentration of LDL protein was due to the limited 
availability of this material. Pilot studies showed that incubation of HepG2 cultures with 
concentrations of total lipoproteins up to 3 mg/mL did not adversely affect morphology or cellular 
integrity of the monolayer. After incubation of cultures in lipoprotein-containing medium for 20 hr, 
monolayers were washed twice with HBSS at 0°C, collected in 1 mL 0.1 mmol/L phosphate 
buffer (pH 7.5), and sonicated for 3-5 seconds using a Sonic Dismembranator at 60% power 
output (Fisher Scientific, Pittsburgh, PA). Aliquots (500 nL) of the sonicate were diluted with an 
equal volume of ethanol (500 ̂ L) containing either echinenone (0.2 ng/mL) or tocol (25 ̂ g/mL) 
as internal standards for analysis of carotenoids or a-tocopherol, respectively. Hydrophobic 
materials were extracted into hexane, dried under nitrogen, reconstituted in the appropriate 
mobile phase, and analyzed by HPLC as below. 
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HPLC Analysis. BC and a-TC were analyzed by HPLC (Hewlett-Packard, model HP-1090, 
Avondale, PA) with a UV/visible dual beam photometer with wavelengths set at 450 nm for 
carotenoids (Bieri et al., 1985) and 292 nm for a-tocopherol (Bieri et al., 1979). The column was 
a Microsorb-MV 5-^meter 25 cm x 0.46 cm diameter C-18 ODS (Rainin, Wobum, MA) and was 
protected by a C-18 Adsorbosphere, 5 nmeter particle size, 0.75 x 0.46 cm guard column 
(Alltech, Deerfield, IL). The mobile phase consisted of 70:20:10 (v/v/v) acetonitrile (with 0.13% 
triethylamine):methylene chloride:methanol (with 0.01% ammonium acetate) at a flow rate of 1.7 
mL/min for estimation of carotenoid concentrations. The mobile phase for quantification of a-TC 
was methanol at a flow rate of 2.5 mL/min. The column temperature was maintained at 20°C 
using a 40 cm HPLC water jacket (Alltech, Deerfield, IL). Data were calculated based on external 
standards that were >94% pure as verified by HPLC. The limits of detection for p-carotene and 
a-tocopherol were 1 and 8 pmol, respectively. Retention times for BC and a-TC were 14.1 and 
5.7 min, respectively. Retention times for other carotenoids, tocopherols and retinoids of 
nutritional interest were also determined using purified standards. Representative 
chromatographic profiles for carotenoids and tocopherols in plasma from control (placebo) and 
p-carotene supplemented individuals are shown in Figures 4.1-4.4 . 
Chemical determinations. Triacylglycerol and cholesterol levels in plasma and lipoprotein 
fractions were determined by commercial kits obtained from Sigma (St. Louis, MO). The protein 
content of cells was determined by a modification of the method by Lowry et al. (1951) using 
bovine serum albumin as a standard. 
Analysis of data. Student's t test was used to determine differences between means. Differences 
were considered significant at p < 0.05. 
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Figures 1-4. Representative chromatograms of p-carotene (BC) and a-tocopherol (a-TC) in 
human plasma from subjects supplementing with p-carotene or placebo for 4 weeks. 
Five healthy adult males in our laboratory volunteered to ingest 60 mg/d p-carotene or placebo 
for 4 weeks. Aliquots of plasma from each subject were extracted and analyzed by high 
performance liquid chromatography (HPLC) to determine concentrations of BC and a-TC. 
Figures 4.1 and 4.3 are chromatograms showing the relative levels of carotenoids and retinoids 
and tocopherols in a sample from a subject ingesting the placebo. Figures 4.2 and 4.4 are 
chromatograms showing the levels of carotenoids and retinol and tocopherols in a sample from a 
subject ingesting the p-carotene supplement for four weeks. The relative size of the p-carotene 
peak is the most evident difference in the profiles. 
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RESULTS 
Our initial aim was to generate BC-enriched lipoproteins by supplementing several 
subjects with 60 mg/d BC. Two independent studies were conducted with individuals assigned to 
ingest either the BC supplement (KM and MF) or the placebo (n=3). Because the response to the 
treatment was similar in both studies, data have been pooled for presentation. The 
concentrations of BC and a-TC in plasma and total lipoproteins of subjects at baseline and after 
4 wk of supplementation with either BC or placebo are shown in Tables 4.1 and 4.2. After 4 
weeks of supplementation with BC, plasma levels of the carotenoid increased more than 13-fold 
above the concentrations of BC in subjects receiving placebo. In the BC-supplemented 
individuals, the concentration of BC was significantly (p<0.05) increased in all lipoprotein 
fractions (Table 4.1). The concentration of BC in total lipoproteins of supplemented subjects after 
4 wk increased 11.5-fold above that in LP of subjects receiving placebo over the same period. 
The magnitude of the increase in lipoprotein fractions was similar with relative distributions as 
follows: 67 + 2% was in LDL, 25 + 3% was in HDL and 8 + 2% in VLDL in subjects at both 
baseline and after 4 wk supplementation with BC. BC concentrations in the plasma and 
lipoprotein fractions of subjects using placebo were similar (p>0.05) at baseline and 4 wk. 
The concentrations of a-TC in plasma were not significantly altered (p > 0.05) by BC 
supplementation for 4 wk (Table 4.2). a-TC was associated primarily with LDL (43 + 5%) with 
lesser amounts in HDL (36 + 1%) and VLDL (21 + 2%). After 4 wk of supplementation with BC, 
the concentration of a-TC (51.6 + 5.1 nmol/L) in total LP (Table 4.2) remained markedly greater 
than the level of BC (4.7 + 0.8 nmol/L; Table 4.1). Plasma lipids were not affected by 
supplementation with either BC or placebo (Table 4.3). Total plasma cholesterol and its relative 
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TABLE 4.1 
Concentrations of p-carotene in human plasma and lipoproteins 
after supplementation with p-carotene or placebo for 4 weeks1 
Baseline 4 week supplement 
|3-carotene placebo 
p-carotene (fimol/L) 
plasma 0.37 + 0.04 5.12 + 0.81* 0.39 + 0.05 
total lipoprotein 0.41 + 0.12 4.71+0.31* 0.46+ 0.07 
VLDL 0.03 + 0.01 0.73 + 0.32* 0.02 + 0.01 
LDL 0.35 + 0.03 3.44 + 0.81* 0.38 + 0.03 
HDL 0.12 + 0.04 1.41+0.30* 0.12 + 0.04 
distribution and concentrations of p-carotene (BC) in human plasma and among lipoprotein (LP) 
fractions were determined in plasma samples collected from healthy male volunteers before 
(n=5) and after supplementation with 60 mg/d BC (n=2) or placebo (n=3) for 4 wk. 
Concentrations of BC were determined by HPLC as described in Materials and Methods. Data 
are pooled means + SE for BC (n=4) and placebo-supplemented subjects (n=5). The presence of 
an asterisk as a superscript indicates significant (p<0.05) differences between means at baseline 
and after 4 wk. VLDL=very low density lipoproteins, LDL-low density lipoproteins, HDL=high 
density lipoproteins. 
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TABLE 4.2 
Concentrations of a-tocopherol in human plasma and lipoproteins 
after supplementation with p-carotene or placebo for 4 weeks1 
Baseline 4 week supplement 
p-carotene placebo 
a-tocopherol (nmol/L) 
plasma 48.6 + 6.0 48.6 + 12.6 48.2 + 5.3 
total lipoprotein 42.3 + 10.5 51.6 + 5.1 42.7+ 7.1 
VLDL 7.8 + 2.4 10.2 + 0.2 11.5 + 4.9 
LDL 22.0 + 2.4 20.1 +0.2 17.8 + 2.7 
HDL 15.9 + 0.4 17.2 + 3.5 17.6 + 5.0 
1 Distribution and concentrations of p-carotene (BC) in human plasma and among lipoprotein (LP) 
fractions were determined in plasma samples collected from healthy male volunteers before 
(n=5) and after supplementation with 60 mg/d BC (n=2) or placebo (n=3) for 4 wk. 
Concentrations of BC were determined by HPLC as described in Materials and Methods. Data 
are pooled means + SE for BC (n=4) and placebo-supplemented subjects (n=4). Mean levels of 
a-TC were not significantly (p > 0.05) altered by supplementation. VLDL=very low density 
lipoproteins, LDL=low density lipoproteins, HDL=high density lipoproteins. 
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TABLE 4.3 
Concentrations of lipids in human plasma and lipoproteins 
after supplementation with p-carotene or placebo for 4 weeks1 
Baseline 4 week supplement 
p-carotene placebo 
(mmol/L) 
total triglycerides 1.1 +0.3 1.4 + 0.5 1.3 + 0.3 
total cholesterol 5.0 + 0.4 4.9 + 0.3 5.0 + 0.3 
VLDL cholesterol 0.5 + 0.1 0.7 + 0.3 0.6 + 0.1 
LDL cholesterol 1.9 + 0.3 2.1 +0.6 2.0 + 0.3 
HDL cholesterol 2.4 + 0.3 1.9 + 0.1 2.0 + 0.3 
1 Distribution and concentrations of lipids in human plasma and among lipoprotein (LP) fractions 
were determined in plasma samples collected from healthy male volunteers before (n=5) and 
after supplementation with 60 mg/d BC (n=2) or placebo (n=3) for 4 wk. Concentrations of 
triglycerides and cholesterol were determined as described in Materials and Methods. Data are 
pooled means + SE for BC (n=4) and placebo-supplemented subjects (n=4). Mean levels of 
lipids were not significantly (p > 0.05) altered by supplementation. VLDL=very low density 
lipoproteins, LDL=low density lipoproteins, HDL=high density lipoproteins. 
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distribution were not affected by supplementation with either BC or placebo with 58 + 3% present 
in LDL, 35 + 4% in HDL and 7 + 1% in VLDL. 
We next compared the stability of BC and a-TC in serum-free tissue culture medium 
after their addition in lipoproteins and micelles. The preparations were incubated for 20 hr using 
standard tissue culture conditions, viz., humidified atmosphere of air: CO2 (95:5) at 37°C in 
sterile plastic multiwell dishes without cells. After overnight incubation, only 27 and 73% of the 
intial concentration of BC and a-TC were present in medium containing micelles with one of the 
test compounds (Table 4.4). In contrast, 88 and 94% of the initial concentrations of BC and a-
TC, respectively, were detected in medium containing the total LP fraction isolated from BC-
supplemented subjects. Inclusion of both a-TC and BC in the micellar preparation markedly 
attenuated the loss of BC during the incubation, suggesting that micellar BC was oxidatively 
modified under standard culture conditions. 
Basal levels of BC in cells that were incubated with PBS only (control) were below the 
level of detection by HPLC (1 pmol/mg protein); levels of a-TC in cells were 6 pmol/mg protein. 
To assess whether HepG2 liver cells accumulated BC and a-TC from lipoproteins, confluent 
cultures were incubated in MEM containing total lipoproteins (1 mg protein/mL) that had been 
prepared from individuals supplemented either with BC or placebo. Cellular levels of BC ranged 
from 1 to 130 pmol/mg protein (Fig. 4.5) and were positively correlated (r=0.94) with the 
concentrations of BC in medium. The cells accumulated 11+2% of BC in medium. The range of 
concentrations of a-TC in HepG2 cells incubated in medium containing total LP from test 
subjects ranged from 53 to 356 pmol/mg protein (Fig. 4.6) and was positively correlated (r=0.74) 
with the concentration of a-TC in medium. Cells accumulated 14 + 2% of medium a-TC. 
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TABLE 4.4 
Effects of standard tissue culture conditions on stability of p-carotene and 
a-tocopherol added to medium as either micelles or lipoproteins1 
Micelle Lipoprotein 
p-carotene 
a-tocopherol 
p-carotene plus 
a-tocopherol 
1 Complete medium containing either micellar preparations or total lipoproteins from BC-
supplemented subjects was incubated in plastic tissue culture dishes without cells in a humidifed 
atmosphere of 95% air: 5% CO2 for 20 hr. The final concentrations of BC and a-TC in medium 
containing micelles were 1.1 and 14.1 î mol/L, respectively. The final concentrations of BC and 
a-TC in medium containing lipoproteins were 4.7 and 41.6 ^mol/L, respectively. Aliquots of 
medium were extracted immediately after preparation and sterilization of medium (n=3) and after 
incubation for 20 hr. The concentrations of BC and a-TC were analyzed as described in Materials 
and Methods. Data are means + SE for at least triplicate samples from two separate 
experiments. 
% initial concentration 
26.8 + 2.3 87.7 + 1.6 
73.1 +2.1 94.0+1.8 
67.8 + 2.0 -
70.9 + 2.3 — 
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Figure 4.5. Accumulation of ̂ -carotene (BC) by HepG2 cultures incubated in MEM containing human 
total lipoproteins. 
Confluent cultures of HepG2 cells were incubated in MEM containing total lipoprotein (1 mg/mL) 
obtained from subjects (n=5) supplementing with either 60 mg/d BC (n=2) or placebo (n=3). Plasma 
samples were collected in two separate studies at the beginning and the end of the supplementation 
period (4 wk) and at 2 and 4 wk post-supplementation to obtain lipoproteins with different concentrations 
of BC. BC was extracted from fresh medium and cells incubated in medium for 20 h. BC was quantified 
by HPLC as described in Materials and Methods. Each point represents the mean value for a test sample 
that was added to three replicate wells. 
93 
C 
0.5 
Q. 
D) 0.4 
0.3 
0.2 
0 3.0 2.0 1.0 4.0 
^•TC in medium (nmol) 
Figure 4.6. Levels ofa-tocopheroI (cx.-TC) in HepG2 cells after overnight incubation in medium containing 
human total lipoproteins. 
Confluent cultures of HepG2 cells were incubated for 20 hr in medium containing human total 
lipoproteins (1 mg/mL) obtained from subjects supplemented with BC or placebo as described in the 
Figure 4.1 legend. Aliquots of fresh medium and cells incubated for 20 hr in test media were extracted 
and analyzed by HPLC to tieierittne a-TC concentrations. Each data point represents the mean value for 
a test sample that was added to three replicate wells. 
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To examine if HepG2 cells preferentially accumulated BC from a specific fraction of 
lipoproteins, cultures were incubated overnight in medium containing either LDL (0.5 mg 
protein/mL) or HDL (1 mg protein/mL) isolated from plasma of subjects. The concentration of BC 
in HepG2 cells incubated overnight in medium with the LDL fraction was 3 to 96 pmol BC/mg 
protein (Fig. 4.7, upper panel) and was positively correlated (r=0.85) with the level of carotenoid 
in the medium. Likewise, cultures incubated in MEM with HDL contained 1 to 14 pmol BC/mg 
protein (Fig. 4.7, lower panel); cellular BC was positively correlated with (r=0.82) the 
concentration in medium. HepG2 cells accumulated 12 + 2 and 20 + 3% of BC introduced into 
medium via LDL and HDL, respectively. 
a-TC levels in cells cultured with LDL also ranged from 54 to 333 pmol a-TC/mg protein 
(Fig. 4.8, upper panel). Similarly, the concentrations of a-TC in HepG2 cells incubated with MEM 
containing HDL ranged from 148 to 365 pmol a-TC/mg protein (Fig. 4.8, lower panel). The 
concentration of a-TC in HepG2 cells was positively correlated with that in medium when 
cultures were incubated with LDL (r=0.74) and HDL (r=0.66). HepG2 cells accumulated 8 + 2 
and 11 + 1% of a-TC added as LDL and HDL to medium, respectively. 
DISCUSSION 
This study demonstrates that BC and a-TC in human lipoproteins are stable in tissue 
culture medium and readily accumulated by HepG2 human liver cells in vitro. Similar to reports 
by Micozzi et al. (1992), we found that supplementation with BC resulted in greater than an 11-
fold increase in the concentration of this carotenoid in plasma and in all lipoprotein fractions 
without altering the relative distribution of BC among lipoprotein subfractions. We also found that 
BC was carried predominantly in the LDL fraction and to a lesser extent in HDL and VLQL, as 
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Figure 4.7. Delivery of p-carotene (BC) to HepG2 cells by human low density lipoprotein (LDL) and high 
density lipoprotein (HDL) tractions. 
Monolayers of HepG2 cells were incubated for 20 hr in medium containing either 0.5 mg/mL human LDL 
(upper panel) or 1 mg/mL HDL (lower panel) obtained from subjects (n=5) supplemented with either 60 
mg/d BC or placebo. Plasma samples were collected at the beginning and end of the 4 wk 
supplementation period and at 2 and 4 wk post-supplementation to obtain lipoprotein fractions with 
different concentrations of BC. After removing spent medium and washing monolayers, cultures were 
harvested, extracted and analyzed to determine cellular BC. Each data point represents the mean value 
for a test sample that was added to three replicate wells. 
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Figure 4.8. Accumulation of a-tocopherol (a-TC) by HepG2 cells incubated in medium containing either 
low density lipoprotein (LDL) or high density lipoprotein (HDL) fractions. 
Confluent monolayers of HepG2 cells were incubated with medium containing either 0.5 mg/mL human 
LDL (upper panel) or 1.0 mg/mL HDL (lower panel) obtained from subjects supplemented with 60 mg/d 
BC or placebo for 4 wk as described in Figure 4.7 legend. Aliquots of fresh medium and cell sonicates 
prepared after 20 hr incubation were extracted and analyzed to determine the concentration of a-TC. 
Each data point represents the mean value for a test sample that was added to three replicate wells. 
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recently reported by Romanchik et al. (1995) and Johnson and Russell (1995). BC 
supplementation did not affect either the concentration or the relative distribution of a-TC in 
lipoproteins which is similar to the findings of Traber et al. (1994) and Ribaya-Mercado et al. 
(1995). 
Our initial goal was to generate BC-enriched lipoproteins for delivery of the carotenoid to 
cells in culture. Because studies regarding the delivery of carotenoids to cells have failed to 
consider the relative stability of the test compounds in cell culture medium, we compared the 
stability of BC and a-TC delivered as micelles and human lipoproteins to MEM and incubated 
overnight using standard tissue culture procedure. Micellar preparations of both compounds, and 
particularly BC, were less stable in tissue culture medium than in lipoproteins. Inclusion of both 
a-TC and BC in the micellar preparation attenuated the loss of BC during incubation, suggesting 
that micellar BC is oxidized under standard tissue culture conditions. In contrast to our data, 
Scita (1993) reported that micellar BC was relatively stable (<4% degraded) in medium that was 
incubated in a humidified atmosphere of air/CC>2 (95:5 v/v) at 37°C for 24 hr. Micelles were 
prepared by adding BC solubilized in tetrahydrofuran-dimethyl sulfoxide to culture medium or 
tetrahydrofuran to Tris buffer containing taurodeoxycholic acid. Cooney et af. (1993) have 
suggested that inclusion of tetrahydrofuran in these preparations may have solubilized and 
stabilized BC by forming a molecular "cage" around one or more BC molecules. It is likely that 
the specific composition of both the micelle and the tissue culture medium, as well as the 
handling of the samples prior to incubation, influences the stability of BC in tissue culture 
medium. 
Numerous investigators have estimated the concentrations and characterized the 
distribution of carotenoids in human lipoproteins (Clevidence and Bieri, 1993; Johnson and 
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Russell, 1995; Traber et al., 1994). However, we are unaware of previous studies evaluating the 
ability of lipoproteins, viz., HDL and LDL, to deliver BC and other carotenoids to cultured human 
cells. Thus, our initial studies focused on the accumulation of BC and a-TC from total 
lipoproteins (LP) by HepG2 cells obtained from subjects supplemented with either BC or 
placebo. Since most hydrophobic compounds in human plasma are associated with LDL and 
HDL, the accumulation of BC and a-TC by HepG2 cultures incubated in medium containing 
these fractions was examined. Our data indicate that confluent cultures of cells readily 
accumulated BC from medium containing either LP, LDL or HDL as the carrier. Moreover, the 
efficiency of BC uptake from LDL and HDL were similar. Comparison of our results with several 
other reports examining BC levels in cells merits consideration. Oarada et al. (1993) reported 
that FU-5 rat hepatoma cells accumulated 70 pmol BC/mg protein when cultures were incubated 
for 24 hr in Ham's F-12 medium containing 3.5 ̂ nrtol/L BC (tetrahydrofuran vehicle). HepG2 cells 
incubated in medium containing total lipoproteins (1 mg protein/mL) isolated from the plasma of 
subjects supplemented with BC accumulated similar quantities of BC. Peng et al. (1994) reported 
2.2 pmol BC/mg protein in human buccal mucosal celts that had been collected from subjects 
supplemented with BC for <10 d. For all fractions, cellular BC was proportional to the quantity of 
BC in the medium added as lipoproteins. 
Confluent cultures of HepG2 cells express LDL receptors and accumulate and 
metabolize human LDL (Javitt, 1990; Dashti and Wolfbauer, 1987). Therefore, it is likely that BC 
accumulation from LDL was mediated at least in part by receptor-mediated endocytosis. 
Although HDL receptors have been identified on the surface of HepG2 liver cells (Javitt, 1990; 
Perova et al., 1988; Dashti et al., 1985), the mechanism by which they facilitate the uptake of 
components of HDL remains unclear. The literature suggests there are two distinct processes for 
uptake of HDL components, viz., one involving endocytotic uptake of apoAl (and thus 
99 
presumably the HDL particle) and the other involving nonendocytotic uptake of cholesterol esters 
mostly without uptake of the particle (Pittman et al.„ 1987). The latter pathway is not limited to 
the uptake of cholesterol esters since a long chain dialkyl ester, sucrose octaoleate, is rapidly 
accumulated from HDL (Pittman et al., 1987). This raises the possibility that the nonendocytotic 
pathway may be important for the uptake of nonpolar compounds such as BC that are carried in 
HDL. Indeed, Leblond and Marcel (1993) reported that HDL cholesterol ester is taken up by 
HepG2 without uptake of the HDL apoprotein. The high affinity plasma membrane receptors for 
HDL in HepG2 cells also appear to mediate the removal of excess intracellular cholesterol, i.e., 
reverse cholesterol transport (McKnight et al., 1992). The cellular binding sites for HDL in intact 
cells is enhanced when cells are loaded with cholesterol or when the rate of cell proliferation is 
inhibited as often observed in confluent cultures. It is unknown if BC and other carotenoids may 
be transferred from the liver cell to HDL by this efflux pathway. Additionally, the extent of 
metabolism of BC by HepG2 cells accumulated in different lipoprotein fractions is unknown. 
The possibility that accumulation of BC from LDL and HDL occurred in part by direct 
transfer of the hydrophobic compounds present in lipoproteins to the hydrophobic plasma 
membrane of HepG2 cells merits further investigation. Indeed, in vitro studies using vehicles 
such as organic solvents, water miscible beadlets and liposomes which lack the components of 
human lipoproteins have resulted in significant cellular accumulation of carotenoids. In our 
studies (see Chapter 3), we have effectively used micelles to deliver BC and a-TC to HepG2 
cells. Systematic investigation of the mechanism(s) of cellular accumulation of carotenoids from 
the different lipoprotein classes is merited. 
In conclusion, this study has demonstrated that BC-enriched lipoprotein fractions are 
relatively stable in human lipoproteins in vitro. Furthermore, lipoproteins represent effective 
vehicles for delivery of BC and other lipophilic compounds to HepG2 human liver cells. 
Together, the use of the highly differentiated human liver cell line and human lipoproteins 
represent a physiologically relevant system for investigating the characteristics of carotenoid 
uptake and metabolism. 
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EPILOGUE 
Over 700 distinct carotenoids have been identified in nature and approximately 100 of these 
compounds are present in the typical United States diet. An increasing body of literature supports 
the potential role of carotenoids as antioxidants and has stimulated interest in this class of 
compounds. The results of my research strongly support the use of the HepG2 human cell line 
as an appropriate model for investigating the purported role of carotenoids as antioxidants in 
protecting various cellular structures and functions against oxidative stress. Moreover, my latter 
studies indicate that carotenoids are readily accumulated by HepG2 cells in vitro from human 
lipoproteins, as well as micelles. However, the focus of numerous studies regarding the potential 
antioxidant activity and metabolism of carotenoids has been limited to only a few compounds 
and particulary ^-carotene. The use of highly differentiated human cell lines coupled with 
carotenoid-enrichment lipoproteins provides a physiologically relevant system for elucidation of 
key questions regarding the metabolic and physiologic functions of carotenoids. If time had 
permitted, I would have initiated several additional studies addressing topics of intense current 
interest regarding carotenoids. These are described in the following sections. 
At least 42 well-controlled epidemiologic studies have been conducted over the past two 
decades and have consistently indicated an inverse correlation between the incidence of several 
forms of cancer in humans and the increased consumption of carotenoid-rich fruits and 
vegetables. A key association that has been regularly noted is the decreased incidence of lung 
cancer in individuals consuming relatively high levels of |3-carotene. This has been of great 
interest and relevance particularly in the United States where smoking is prevalent. However, 
two recent studies have provided compelling evidence that supplementation with high levels of 
p-carotene actually may be associated with increased occurrence and severity of lung cancer 
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and particularly for those individuals who smoke. To address these conflicting observations, I 
propose development of a cell model to investigate the potential role of p-carotene in the 
exacerbation of lung pathology in individuals who smoke. Anchorage-dependent human cells of 
bronchiolar (i.e. CCD-14Br) or lung carcinoma (alveolar) origin (i.e. WI-38) would be obtained 
from ATCC and cultured on semipermeable membranes. Medium containing human lipoproteins 
or micelles enriched with p-carotene would be added to the basolateral compartment of confluent 
monolayers to simulate the in vivo delivery of carotenoids from the plasma. Since BC and a-TC 
are both transported in lipoproteins, enrichment of the particles with BC without altering the 
profile of a-tocopherol would facilitate my focus on |3-carotene. After overnight incubation, 
medium would be removed and cultures washed rigorously before transferring cultures to a 
separate incubator maintained at 37°C and air to mimic the partial pressure of oxygen of inhaled 
ambient air. Medium containing cigarette smoke extract (CSE) would be prepared using a 
vacuum driven glass apparatus currently used in Dr. Loo's laboratory. Smoke from cigarettes 
couid be passed through medium allowing entrapment of contaminants of cigarette smoke in the 
fluid matrix which would simulate pulmonary secretions. Filter sterilized medium containing the 
CSE would then be added to the apical compartment and cultures would be incubated for various 
times. Medium from both the upper and lower compartments would be examined to assess the 
effects of treatment on the structural integrity and metabolic activities of the cells as described in 
Chapters 2 and 3. It is noteworthy that BC has been reported to act as a pro-oxidant at high 
oxygen tensions such as that typically encountered in the lung, whereas a-tocopherol is a potent, 
effective antioxidant at high oxygen tension. Therefore, I also would analyze the concentrations 
of these two compounds in the test cell type. The information gained in these studies would 
begin to provide new insights about the relationship between the two antioxidants in cells of 
pulmonary origin and their role in attenuating free radical-mediated damage often associated 
with cytotoxicity and neoplasia. 
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Fat soluble vitamins and carotenoids are absorbed via emulsification with pancreatic and 
biliary secretions in the lumen of the intestine. A major concern regarding reported human 
studies evaluating the differential absorption of carotenoids has been the potential for interaction 
of carotenoids in the intestine and the relative impact on absorption of individual carotenoids. 
Numerous human studies have provided conflicting evidence for interaction of specific 
carotenoids in the intestinal lumen. Additionally, the recent approval of OlestraR (Procter & 
Gamble) by the Food and Drug Administration has prompted intense debate over the use of this 
fat substitute and similar products and the potential compromise of antioxidant status in 
individuals as a result of decreased absorption of fat soluble vitamins and compounds. The use 
of highly differentiated human intestinal cell lines, viz., Caco-2, would provide a tool to evaluate 
carotenoid interactions and the effects of compounds such as Olestra on the uptake and 
absorption of carotenoids. Caco-2 human intestinal cells would be cultured on semipermeable 
membranes as described in Chapter 2. Confluent differentiated monolayers would be incubated 
with micellar preparations of a test carotenoid alone or in combination with either other 
carotenoids or fat soluble compounds such as a-tocopherol and Olestra, in the apical 
compartment to simulate the lumenal environment of the small intestine. After various times, 
medium would be removed and the monolayers washed rigorously. The accumulation of the 
carotenoids would be analyzed by high performance liquid chromatography. Information from 
these studies would provide insights about the efficacy of use of synthetic macronutrient 
substitutes and elucidate the relative impact of disproportionate consumption of fat soluble 
compounds such as p-carotene supplements. Moreover, the model would facilitate the 
development of rational recommendations concerning the beneficial and detrimental effects of 
carotenoid supplementation and fat substitutes. 
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As an extension of studies regarding the interaction of carotenoids, the culture of Caco-2 
cells on microporous inserts would also allow evaluation of metabolic modification of carotenoids 
since very little is currently known. Both cellular and secretory metabolites (basolateral) could 
possibly be identified and quantified providing important informaton on the disposition of 
carotenoids during absorptive and post-absorptive periods within the human gut. Moreover, the 
inclusion of a second cell type within the culture system, i.e., a co-culture technique, has the 
potential for evaluating distribution of carotenoids and their metabolites. For example, cultures of 
HepG2 human liver cells, adipocytes or myocytes could be grown on multiwell dishes and Caco-
2 intestinal cells grown on microporous membrane inserts and placed into those wells to evaluate 
absorption and tissue-specific uptake, or metabolism of carotenoids. 
Finally, the development of a cellular model for evaluation of carotenoids as antioxidants 
has also provided the means for evaluating the potential roles of other compounds as 
antioxidants. For instance, human lipoproteins transport lipophilic carotenoids and numerous 
other compounds with potential antioxidant activity, viz., ubiquinol-10. Additionally, there has 
been increasing interest in the role of a group of plant compounds called flavonoids as potential 
antioxidants. The described cell models provide a valuable screening tool for determination of 
antioxidant potential. Inclusion of the well-established lipophilic antioxidant a-tocopherol would 
allow the development of a relative index of cytoprotection. Together, these results would 
provide insight into the activity and potency of numerous dietary compounds and potentially 
facilitate recommendations for dietary practices. 
The initiation of projects addressing the aforementioned questions would provide novel 
information about the functions, distribution and metabolism of carotenoids and other potentially 
beneficial dietary compounds. The challenge will be given to other students because I face new 
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opportunities at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts 
University. 
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